<SEC-DOCUMENT>0001493152-23-002455.txt : 20230125
<SEC-HEADER>0001493152-23-002455.hdr.sgml : 20230125
<ACCEPTANCE-DATETIME>20230125163210
ACCESSION NUMBER:		0001493152-23-002455
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230119
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20230125
DATE AS OF CHANGE:		20230125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jupiter Wellness, Inc.
		CENTRAL INDEX KEY:			0001760903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				832455880
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39569
		FILM NUMBER:		23552836

	BUSINESS ADDRESS:	
		STREET 1:		1061 E. INDIANTOWN RD.
		STREET 2:		STE. 110
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477
		BUSINESS PHONE:		561-325-0482

	MAIL ADDRESS:	
		STREET 1:		1061 E. INDIANTOWN RD.
		STREET 2:		STE. 110
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CBD Brands, Inc.
		DATE OF NAME CHANGE:	20181206
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:JUPW="http://jupiterwellness.com/20230119">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_JUPW_jupiterwellness.com_20230119 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20230119_20230119 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001760903 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityCentralIndexKey">0001760903</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="jupw-20230119.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-19to2023-01-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-192023-01-19_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001760903</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">JUPW:WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-19</xbrli:startDate>
        <xbrli:endDate>2023-01-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C., 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90E_edei--DocumentType_c20230119__20230119_zInm8dBMfpNb"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_908_edei--DocumentPeriodEndDate_c20230119__20230119_zxFWnPVZHvX2"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 19, 2023</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20230119__20230119_zR61wTepZrkg"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityRegistrantName">JUPITER
WELLNESS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20230119__20230119_zvre0Z5mX4Mj"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20230119__20230119_zchlLYdAafR"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityFileNumber">001-39569</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20230119__20230119_z19pdaUbmbDf"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityTaxIdentificationNumber">83-2455880</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction
    <br />
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission <br />
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer <br />
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20230119__20230119_zLU3nkFQryO1"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressAddressLine1">1061
E. Indiantown Rd.</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20230119__20230119_zRhAnSlQ89Xh"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressAddressLine2">Ste. 110</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressCityOrTown_c20230119__20230119_zVwFWg3noBTh"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressCityOrTown">Jupiter</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20230119__20230119_ztDZA5mTjAve"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20230119__20230119_zKcGYnMMxdHg"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityAddressPostalZipCode">33477</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices) (Zip Code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--CityAreaCode_c20230119__20230119_zyhiqK3bd9db"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:CityAreaCode">(561)</ix:nonNumeric></span>
<span id="xdx_90D_edei--LocalPhoneNumber_c20230119__20230119_z59r1hcwY0Ia"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:LocalPhoneNumber">244-7100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityInformationFormerLegalOrRegisteredName_c20230119__20230119_zFfqoNPXB4Wa"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" name="dei:EntityInformationFormerLegalOrRegisteredName">Not
Applicable</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (<span style="text-decoration: underline">see</span> General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--WrittenCommunications_c20230119__20230119_z8hnN0beZJSf"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--SolicitingMaterial_c20230119__20230119_zl9qxLLAIgg1"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20230119__20230119_z6jW5apyNc6j"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20230119__20230119_z0MiAFlImR56"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of
    each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each
    exchange on which registered </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zF8rkcLbEtx9"><ix:nonNumeric contextRef="From2023-01-192023-01-19_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zJYVinXpvIPj"><ix:nonNumeric contextRef="From2023-01-192023-01-19_us-gaap_CommonStockMember" name="dei:TradingSymbol">JUPW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--SecurityExchangeName_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zNhK8c9MA0td"><ix:nonNumeric contextRef="From2023-01-192023-01-19_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(The
    Nasdaq Capital Market)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--Security12bTitle_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_ziJyIXABp2Va"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" name="dei:Security12bTitle">Warrants, each exercisable
    for one share of Common Stock at $8.50 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_zxZx2CQU6Xzb"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" name="dei:TradingSymbol">JUPWW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SecurityExchangeName_c20230119__20230119__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_z9Yov1vt0CIg"><ix:nonNumeric contextRef="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(The
    Nasdaq Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20230119__20230119_zinp2bL12cDd"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90E_edei--EntityExTransitionPeriod_c20230119__20230119_zjOWYvf3Lozg"><ix:nonNumeric contextRef="From2023-01-19to2023-01-19" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1.01.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
                                            into a Material Definitive Agreement</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIPE
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">On
January 19, 2023, Jupiter Wellness, Inc., (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement (the &#8220;PIPE Agreement&#8221;)
with certain purchasers, for the issuance of 8,631,574 common stock warrants (the &#8220;PIPE Offering&#8221;) at
a price of $0.125 per warrant, comprised</span> <span style="font: normal 10pt Times New Roman, Times, Serif">of
two common stock warrants (the &#8220;Common Warrants,&#8221;), each to purchase up to one share of Common Stock per Common Warrant with
an exercise price of $1.00 per share , with (a) 4,315,787 Common Warrants being immediately exercisable for three
</span><span style="font: normal 10pt Times New Roman, Times, Serif">years
following 6 months from the closing of the PIPE Offering, and (b) 4,315,787 Common Warrants being immediately exercisable for five
</span><span style="font: normal 10pt Times New Roman, Times, Serif">years
following 6 months from the closing of the PIPE Offering.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>RD
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2023, The</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
entered into a Securities Purchase Agreement (the &#8220;RD Agreement&#8221;) with certain purchasers, pursuant
to which on January 23, 2023, 4,315,787 shares of common stock,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par
value $0.001 (the &#8220;Common Stock&#8221;), at a price of $0.70 per share were issued to the purchasers
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;RD Offering&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock was</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued
pursuant to a Registration Statement on Form S-3 filed by the Company with the Securities and Exchange Commission (the &#8220;Commission&#8221;)
on September 28, 2022 (File No. 333-267644) and declared effective on November 9, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate gross proceeds to the Company from</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">both
the PIPE Offering and the RD Offering were approximately $4.1 million, with the purchase price of one share, one 3-year warrant and one
5-year warrant as $0.95.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2023, the Company also entered into a Registration Rights Agreement with the Purchasers, (the &#8220;Registration Rights
Agreement&#8221; and together with the PIPE Agreement and the RD Agreement the &#8220;Agreements&#8221;), requiring the Company to register
the securities issued under the PIPE Agreement. Pursuant to the Rights Registration Agreement, the Company has agreed to file one or
more registration statements with the SEC covering the registration of the shares of Common Stock issuable upon exercise of the Common
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PIPE Agreement, the RD Agreement, and the Registration Rights Agreement, are filed as Exhibits 10.1, 10.2, and 10.3, respectively, to
this Current Report on Form 8-K and are incorporated herein by reference. The above descriptions of the terms of the Agreements are qualified
in their entirety by reference to such exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 3.02</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
                                            Sales of Equity Securities</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable information related to PIPE Agreement presented in Item 1.01 of this Current Report is incorporated by reference in this Item
3.02. The Common Warrants <span style="background-color: white">will be issued without prior registration in reliance upon the exemption
from registration provided by Section 4(a)(2) of the Securities Act, and Rule 506(b) of Regulation D thereunder.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 8.01.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Events</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
Price Reduction</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
previously disclosed, the Company had registered for sale under a Registration Statement on Form S-1 with the Commission on July 26,
2021 (File No. 333-258005), warrants to purchase up to 11,607,142 shares of Common Stock (the &#8220;2021 Warrants&#8221;). The 2021
Warrants were initially exercisable at a $2.79 per share price, which is now being reduced to $1.40 per
share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Press
Release</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 23, 2023 the Company issued a press release announcing the various transactions described herein. A copy of the press release
is attached hereto as Exhibit 99.1, and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.01</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-01.htm">Form of the PIPE Securities Purchase Agreement, dated January 19, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.02</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-02.htm">Form of the RD Securities Purchase Agreement, dated January 19, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.03</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-03.htm">Form of the Registration Rights Agreement, dated January 19, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.01</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-01.htm">Press Release dated January 23, 2023</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">104</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (embedded with the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
January 25,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JUPITER WELLNESS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Brian John</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Brian John</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kEFuwjAQRU/AHUZRlwicUNQqOxoFVBUKAtR2a5JJsUg80dhQOFJvWcdpBIvWsmRZf/773w6CfjCjqSqR4eNpPYctVnUpLcIaC2TUGbqJ5PklBneu8VMZy1Jbf+2MCTkPOs94ED5IJ/jRkzKYxyDCYXQ/jEYgRrEIYbUIeo2ekC5UjtoqWYLUOayYalZoJV9awlaeSVN18VFvyEaRjiEciFb+hkiEEbzSSX4RHwzM50nQ6/vVC2ZMx7qJORpLFaQlVi7LtNbr9lUyPxO/S25eZlKZ7dMzcqaM3JU4JV5q3Owl47JwL61Ibyxlh4l9HIzFCtlLC6x2yA4Wisj1mvyW7Jh9QEcFvGKhIAbSCKaxAxXQssHDQVq4a/hQu//1I380vmnzT/4tswP8AMfKltw= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.01
<SEQUENCE>2
<FILENAME>ex10-01.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
<FONT STYLE="text-transform: uppercase">10.01</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PIPE
SECURITIES PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
PIPE Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of January 19, 2023, between Jupiter Wellness, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (including their
respective successors and assigns, each a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser,
and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described
in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In
Price</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, $0.001 par value per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means the warrants to purchase shares of Common Stock delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which Common Warrants shall be in the forms of <U>Exhibit A-1</U> and <U>Exhibit A-2</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means with respect to U.S. federal securities law and New York law, Sichenzia Ross Ference LLP, 1185 Avenue of the
Americas, 31st Floor, New York, NY 10036.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disqualification
Event</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>DVP</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares and Warrant
Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or
may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required
under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided
that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold
pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions
and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders
of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such
holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means (i) any conventional bank loans that are not convertible into shares of Common Stock or Common Stock Equivalents
and do not involve any issuance of any shares of Common Stock or Common Stock Equivalents or other security of the Company in connection
therewith; (ii) shares of Common Stock or options issued to employees, officers or directors of the Company pursuant to the Company&rsquo;s
equity incentive plans or pursuant to the compensation agreements previously authorized by the Board of Directors; (iii) securities issued
upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities; and (iv) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith during the period
of one hundred and twenty (120) days following the Release Date and provided that any such issuance shall only be to a Person (or to
the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(uu).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(uu).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Covered Person</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>IT
Systems and Data</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(vv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors, executive
officers, employees and shareholders holding at least ten (10%) of the outstanding shares of Common Stock on a fully converted basis,
in the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Money
Laundering Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(qq).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Warrant Purchase Price</U>&rdquo; equals $0.125, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>PFIC</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.18.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(uu).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Aegis Capital Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent Agreement</U>&rdquo; means the placement agent agreement, dated on or about the date hereof, between the Company and the Placement
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in
accordance with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in
full, in the form of <U>Exhibit A-3</U> attached thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>RD
Purchase Agreement</U>&rdquo; means the securities purchase agreement as of the date hereof for the issue and sale of approximately $3
million of Common Stock and pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated as of the date hereof, by and among the Company and the Purchaser
Parties, in the form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Release
Date</U>&rdquo; means the latest of (i) the Effective Date, (ii) the date that the Company obtains the Shareholder Approval or a Board
Approval in lieu of Shareholder Approval to effect the purposes of the Shareholder Approval and (iii) the Initial Exercise Date of the
Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the shareholders of the Company (a) to render inapplicable clause (i) of the definition of the Floor Price in
Section 3(b) of the Warrants, (b) to consent to the voluntary adjustment, from time to time, of the exercise price of any and all currently
outstanding warrants, subject to a minimum exercise price of $0.25, (c) to consent to any adjustment to the exercise price or number
of shares of Common Stock underlying the Warrants in the event of a Share Combination Event (as defined in the Warrants).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SRM
Spin-Off</U>&rdquo; means the spin-off of the Company&rsquo;s subsidiary, SRM Entertainment, Inc., in the previously announced spin-off
and the listing of SRM on the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the OTCQB, OTCQX, Pink Open Market (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Securities, the Registration Rights Agreement, the Placement Agent Agreement, the Lock-Up
Agreement and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions
contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598 and an email address of young@vstocktransfer.com, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; means a transaction in which the Company (i) issues or sells any shares of Common Stock or Common Stock Equivalents
either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading
prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B)
with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt
or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company
or the market for the Common Stock, other than in connection with customary anti-dilution adjustments resulting from future stock splits,
stock dividends or similar transactions, or (ii) issues or sells any amortizing convertible security that amortizes prior to its maturity
date, whereby it is required to or has the option to (or the investor in such security has the option to require the Company to) make
such amortization payments in Common Stock (whether or not such payments in stock are subject to certain equity conditions) or (iii)
enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or &ldquo;at-the-market&rdquo;
offering, whereby it may sell securities at a future determined price, regardless of whether shares pursuant to such agreement have actually
been issued and regardless of whether such agreement is subsequently canceled, provided that any issuance of shares upon the exercise
of the Common Warrants issuable hereunder will not be deemed a Variable Rate Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the OTC Pink (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Pre-Funded Warrants and the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of approximately $1 million of Warrants. Each Purchaser shall deliver to the Company, via wire
transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed
by such Purchaser, and the Company shall deliver to each Purchaser its respective Warrants, as determined pursuant to Section 2.2(a),
and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of counsel to the Placement
Agent or such other location (or remotely by electronic means) as the parties shall mutually agree. Unless otherwise directed by the
Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on
the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer
Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent
shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent
(or its clearing firm) by wire transfer to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
on the date hereof, (a) this Agreement duly executed by the Company and (b) a certificate executed by the Chief Financial Officer of
the Company in customary form reasonably satisfactory to the Placement Agent and its counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable to
the Placement Agent and Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the number stated
on such Purchaser&rsquo;s signature page hereto, each with an exercise price equal to $1.00, subject to adjustment as provided therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the
Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
on the date hereof, the Lock-Up Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
on the date hereof, a copy of resolutions of the Board of Directors that evidence the voluntary adjustment of the exercise price of all
warrants issued on July 26, 2021 from $2.79 to $1.40;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
a duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the Registration Rights Agreement duly executed by the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
a cold comfort letter from the Company&rsquo;s auditor, addressed to the Placement Agent in form and substance reasonably satisfactory
in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Registration Rights Agreement duly executed by such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). Except as set forth
in Schedule 3.1(a), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free
and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;Material Adverse
Effect&rdquo;; provided, however, that &ldquo;Material Adverse Effect&rdquo; shall not include any event, occurrence, fact, condition
or change, directly or indirectly, arising out of or attributable to: (i) general economic or political conditions, (ii) conditions generally
affecting the industry in which the Company or any Subsidiary operates, (iii) any changes in financial or securities markets in general,
(iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof, (v) any pandemic,
epidemics or human health crises (including COVID-19), (vi) any changes in applicable laws or accounting rules (including GAAP), (vii)
the announcement, pendency or completion of the transactions contemplated by the Transaction Documents, or (viii) any action required
or permitted by the Transaction Documents or any action taken (or omitted to be taken) with the written consent of or at the written
request of Purchaser) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filings with the Commission pursuant to the Registration Rights Agreement,
(iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing
of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, (iv) the filing of Form D with the Commission,
(v) the Shareholder Approval and such other filings as are required to be made under applicable state securities laws (the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable (which means that no further sums are required to
be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents and applicable law. The Warrant Shares, when issued in accordance with the terms
of the Transaction Documents, will be validly issued, fully paid and nonassessable (which means that no further sums are required to
be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents and applicable law. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g)(1), which Schedule
3.1(g)(1) shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. Other than as stated in Schedule 3.1(g)(1), the Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s
stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in Schedule 3.1(g), there are no outstanding options, warrants, scrip
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the
capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance
and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any
Person (other than the Purchasers). Except as set forth in Schedule 3.1(g)(2), there are no outstanding securities or instruments of
the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument
upon an issuance of securities by the Company or any Subsidiary. Except as set forth in Schedule 3.1(g)(2), there are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued,
fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There
are no stockholders&rsquo; agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock
to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is not currently an
issuer subject to Rule 144(i) under the Securities Act. The Company has filed Form 10 information at least one year prior to the date
hereof. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis
during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes
thereto, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on Schedule 3.1(i), (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or
their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one (1) Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth in Schedule 3.1(j), there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on Schedule 3.1(j), (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or (ii) would, if there were an unfavorable decision, have
or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company except in the ordinary
course of business that would not have a Material Adverse Effect. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable
rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for (i) Liens that do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)
Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP, and the
payment of which is neither delinquent nor subject to penalties. Neither the Company nor any of its Subsidiaries has received any written
notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Company or its Subsidiaries under any of
the leases or subleases or licenses or with respect to the properties mentioned above, or affecting or questioning the rights of the
Company or any Subsidiary to the continued possession or use of the leased or subleased or licensed premises or the properties mentioned
above, other than such claims which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received written notice that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the
Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth on Schedule 3.1(r), during the past three fiscal years and the
subsequent interim period through the date of this Agreement, none of the officers or directors of the Company or any Subsidiary and,
to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. Except as set forth on
Schedule 3.1(s), the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have
evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The
Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Except as disclosed on Schedule 3.1(w) and other than to each of the Purchasers pursuant to the Registration
Rights Agreement, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act
of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All
of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, is true and correct and does not contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which
they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any
such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of
the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither The Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Tax Status</U>. Except as disclosed in Schedule 3.1(cc), the Company and its Subsidiaries each (i) has made or filed all material
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii) has paid all material taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Foreign Corrupt Practices Act</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Accountants</U>. The Company&rsquo;s accounting firm is M&amp;K CPAs, PLLC. To the knowledge and belief of the Company, such accounting
firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the
financial statements to be included in the Company&rsquo;s Annual Report for the now current fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>No Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(g) and 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent in connection
with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Purchasers
shall be deemed a representation and warranty by the Company to the Purchasers as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires most recently completed
by each of the Company&rsquo;s directors and officers and beneficial owner of 5% or more of the shares of Common Stock or Common Stock
Equivalents is true and correct in all respects and the Company has not become aware of any information which would cause the information
disclosed in such questionnaires become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan, if any, was granted
(i) in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair
market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option
granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has
been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options
with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>FDA</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under
the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
<U>Cybersecurity</U>. (i) (x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any
Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and
Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use,
access, misappropriation or modification, except, in the case of clauses (i) and (ii) herein, as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the law of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the legal, valid and binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; as defined in Rule 144 and
have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal
for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities
Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute
or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation
and warranty shall not limit such Purchaser&rsquo;s right to sell the Securities pursuant to a registration statement or otherwise in
compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course
of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as
defined in Rule 144A(a)(1) under the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule
506(d) Related Parties (as defined below) is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities
Act. For purposes of this Agreement, &ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad
Actor disqualification&rdquo; provision of Rule 506(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>General Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be and has not been provided to it (other than with respect
to the transactions contemplated by the Transaction Documents). In connection with the issuance of the Securities to such Purchaser,
neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in substantially
the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective
under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance
with the current public information required under Rule 144 (assuming cashless exercise of the Warrants), (iii) if such Shares or Warrant
Shares are eligible for sale or may be sold under Rule 144 (assuming cashless exercise of the Warrants), without volume or manner-of-sale
restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer
Agent or the Purchaser if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser,
respectively. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
resale of the Warrant Shares, if the Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the
current public information required under Rule 144 (assuming cashless exercise of the Warrants), or if the Shares or Warrant Shares may
be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under
Rule 144 as to such Shares or Warrant Shares or if such legend is not otherwise required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission), then such Shares or Warrant Shares
shall be issued free of all legends. The Company agrees that following the earliest of the Effective Date (for purposes of this Section
4.1(c), as to some or all Shares or Warrant Shares) or such time as such legend is no longer required under this Section 4.1(c), it will,
no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as
defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant
Shares, as the case may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause
to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company
may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth
in this Section 4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the
Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such
Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo; means the standard settlement period, expressed in a number of Trading
Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate
representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend. In addition to such Purchaser&rsquo;s other
available remedies, the Company shall pay to the Purchaser, in cash, as partial liquidated damages and not as a penalty, 2% of the total
of the value of the Shares or Warrant Shares for which the removal of the legend is sought (based on the VWAP of the Common Stock on
the date such Shares or Warrant Shares are submitted to the Transfer Agent) for each full month that said opinion is not delivered after
the Legend Removal Date until such certificate is delivered without a legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock
that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such
Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common
Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In Price</U>&rdquo;)
over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend
Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the
date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the
date of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information; Public Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until no Purchaser owns any Securities and the Warrants have terminated, the Company covenants to maintain the effectiveness of the registration
of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to use reasonable best efforts to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the
Securities (assuming cashless exercise for the Warrants) may be sold without the requirement for the Company to be in compliance with
Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to
satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or
becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public
Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser,
in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities,
an amount in cash equal to two percent (2.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities on the day of
a Public Information Failure and on every thirtieth (30th) day (prorated for periods totaling less than thirty days) thereafter until
the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required
for the Purchasers to transfer the Shares and Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled
pursuant to this Section 4.2(b) are referred to herein as &ldquo;Public Information Failure Payments.&rdquo; Public Information Failure
Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments
are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Public Information Failure Payments
is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure
Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit
such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to
pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file, within the time required by the Exchange Act, a Current Report on Form 8-K,
including the Transaction Documents as exhibits thereto, with the Commission. From and after the issuance of such press release, the
Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the
Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents (including,
without limitation, the Placement Agent) in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries, or any of their respective officers, directors,
agents (including, without limitation, the Placement Agent), employees or Affiliates on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) to the extent required by federal securities law in connection with (i) any registration statement contemplated by this Agreement
or the Registration Rights Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such
disclosure is required by law or Trading Market regulations, in which such cases the Company shall (x) obtain prior advice of competent
counsel that such disclosure is required, (y) provide the Purchasers with prior notice of such disclosure permitted under this Section
4.4 and (z) reasonably cooperate with such Purchasers regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents,
employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to
applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes
(which for the avoidance of doubt may include acquisitions, in the Company&rsquo;s discretion), including working capital. The Company
shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade payables
in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any shares of Common Stock or
Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct)
or (c) in connection with any registration statement of the Company providing for the resale by the Purchasers of the Shares or Warrant
Shares issued and issuable upon exercise of the Warrants, the Company will indemnify each Purchaser Party, to the fullest extent permitted
by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material
fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or
in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in the light of the circumstances
under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are
based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for
use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities
law, or any rule or regulation thereunder in connection therewith). If any action shall be brought against any Purchaser Party in respect
of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the
Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party.
Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof
has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such
defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for
the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under
this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not
be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or
others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Listing of Common Stock</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which
it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares
on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application
all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to
be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary
to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In addition, the Company shall hold a special meeting of shareholders (which may also be at the annual meeting of shareholders) at the
earliest practicable date after the date hereof, but in no event later than April 24, 2023 for the purpose of obtaining Shareholder Approval,
if required to effect the purpose thereof, with the recommendation of the Company&rsquo;s Board of Directors that such proposal be approved,
and the Company shall solicit proxies from its shareholders in connection therewith in the same manner as all other management proposals
in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall
use its reasonable best efforts to obtain such Shareholder Approval, and officers, directors and shareholders subject to the Lock-Up
Agreement shall cast their proxies in favor of such proposal. If the Company does not obtain Shareholder Approval at the first meeting,
the Company shall call a meeting every four (4) months thereafter to seek Shareholder Approval until the earlier of the date Shareholder
Approval is obtained or the Warrants are no longer outstanding. Notwithstanding the foregoing, the Company may, in lieu of holding a
special meeting of shareholders as aforesaid, obtain the written consent of a majority of its shareholders covering the Shareholder Approval
so long as prior to April 24, 2023, such written consents are obtained and in accordance with Exchange Act Rule 14c-2 at least twenty
(20) days shall have transpired from the date on which a written information statement containing the information specified in Schedule
14C detailing such Shareholder Approval shall have been filed with the SEC and delivered to shareholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until one hundred and twenty (120) days after the Release Date, neither the Company nor any Subsidiary shall (i)
issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock
Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant
to the Registration Rights Agreement or, solely with respect to securities issued pursuant to any share or option plan duly adopted for
such purpose by the Board of Directors or a committee of non-employee directors established for such purpose for services rendered to
the Company, on Form S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until twelve (12) months from the Release Date, the Company and its Subsidiaries shall be prohibited from effecting
or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock
Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive
relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.10 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance. In addition, nothing in this Agreement shall prohibit the Company from effecting the SRM Spin-Off.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the
foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that
(i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, agents or Affiliates after the issuance of the initial press release as described
in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Capital Changes</U>. Until the date that is one hundred and eighty (180) days after the Release Date, not including any days following
six (6) months after the Closing Date on which current public information is unavailable in accordance with Rule 144(c)(1), the Company
shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior written consent of the
Purchasers holding a majority in interest of the Shares and Pre-Funded Warrants, based on the initial Subscription Amounts hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant
to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive
effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek
specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Registration Rights Agreement</U>. On the date hereof, the Company shall enter into the Registration Rights Agreement and shall not
amend, modify, waive or terminate any provision of the Registration Rights Agreement, except pursuant to the terms of the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>QEF Election</U>. If a Purchaser so requests in writing for any taxable year of the Company, the Company, after consulting with its
outside accounting firm, shall within 15 Business Days notify such Purchaser in writing that either (A) neither the Company nor any of
its Subsidiaries was a &ldquo;passive foreign investment company&rdquo; as defined in Section 1297 of the Code (&ldquo;PFIC&rdquo;) for
such year, or (B) the Company and/or one or more of its Subsidiaries was a PFIC for such year, in which event the Company shall provide
to such Purchaser, upon the reasonable written request of such Purchaser, the information reasonably necessary to allow such Purchaser
to elect to treat each of the Company and any applicable Subsidiaries (if any), respectively, as a &ldquo;qualified electing fund&rdquo;
(within the meaning of Section 1295 of the Code for such year, including a &ldquo;PFIC Annual Information Statement&rdquo; as described
in Treasury Regulation Section 1.1295-1(g)(1) (or any successor Treasury Regulation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded
Warrants based on the initial Subscription Amounts hereunder (or, prior to Closing, the Company and each Purchaser) or, in the case of
a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of
the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the law of the State of New York. Each party agrees that all legal
Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other
Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners,
members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City and County of New York for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any
Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any
provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party
in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent
any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms
and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.
It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
PIPE Securities Purchase Agreement Signature Pages Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
PIPE Securities Purchase Agreement &ndash; Company Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JUPITER
    WELLNESS, INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    bjohn@jupiterwellness.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    John</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
PIPE Securities Purchase Agreement &ndash; Investor Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has caused this Securities Purchase Agreement to be duly executed by its authorized signatory as of
the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Purchaser:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Purchaser:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice to Purchaser:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Amount</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
    (remaining unpaid aggregate exercise price $[&#9679;] for pre-funded warrants)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-funded
    Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Ownership Blocker:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Ownership Blocker:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employer
    Identification Number: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.02
<SEQUENCE>3
<FILENAME>ex10-02.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>E</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: lowercase">xhibit
</FONT></B><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.02</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>RD
SECURITIES PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
RD Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of January 19, 2023, between Jupiter Wellness, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (including their
respective successors and assigns, each a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), and Rule 506 promulgated thereunder, the Company desires to issue
and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In
Price</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd) Trading
Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, $0.001 par value per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means the warrants to purchase shares of Common Stock delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) of the Private Placement Purchase Agreement, which Common Warrants shall be in the form of <U>Exhibit A-1</U> and <U>Exhibit
A-2</U> attached thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means with respect to U.S. federal securities law and New York law, Sichenzia Ross Ference LLP, 1185 Avenue of the
Americas, 31st Floor, New York, NY 10036.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disqualification
Event</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>DVP</U>&rdquo;
shall have the meaning ascribed to such term in Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; shall have the meaning assigned to it in the Private Placement Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means (i) any conventional bank loans that are not convertible into shares of Common Stock or Common Stock Equivalents
and do not involve any issuance of any shares of Common Stock or Common Stock Equivalents or other security of the Company in connection
therewith; (ii) shares of Common Stock or options issued to employees, officers or directors of the Company pursuant to the Company&rsquo;s
equity incentive plans or pursuant to the compensation agreements previously authorized by the Board of Directors; (iii) securities issued
upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities; (iv) any securities issued in connection with the contemplated spin off of SRM Entertainment, Inc. and (v) securities issued
pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that
such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require
or permit the filing of any registration statement in connection therewith during the period of one hundred and twenty (120) days following
the Release Date and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(uu).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(uu).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Federal
Reserve</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Covered Person</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>IT
Systems and Data</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(vv).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors, executive
officers, employees and shareholders holding at least ten percent (10%) of the outstanding shares of Common Stock on a fully converted
basis, in the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Money
Laundering Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(qq).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>OFAC</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(nn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $0.70 (less $0.001 for each Pre-Funded Warrant), subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>PFIC</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.18.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(uu).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Aegis Capital Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent Agreement</U>&rdquo; means the placement agent agreement, dated on or about the date hereof, between the Company and the Placement
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in
accordance with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in
full, in the form of <U>Exhibit A-3</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Private
Placement Purchase Agreement</U>&rdquo; means the securities purchase agreement as of the date hereof for the issue and sale of approximately
$1 million of Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Private
Placement Registration Rights Agreement</U>&rdquo; means the registration rights agreement, dated as of the date hereof, by and among
the Company and the purchasers party to the Private Placement Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final base prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-3 with Commission (File No. 333-267644), including all information,
documents and exhibits filed with or incorporated by reference into such registration statement, which registers the sale of the Securities
to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Release
Date</U>&rdquo; means the later of (i) the Effective Date and (ii) the date that the Company obtains the Shareholder Approval (as such
term is defined in the Private Placement Purchase Agreement) or a Board Approval in lieu of Shareholder Approval to effect the purposes
of the Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the OTCQB, OTCQX, Pink Open Market (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Securities, the Placement Agent Agreement, the Lock-Up Agreement and all exhibits and
schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598 and an email address of young@vstocktransfer.com, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; means a transaction in which the Company (i) issues or sells any shares of Common Stock or Common Stock Equivalents
either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading
prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B)
with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt
or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company
or the market for the Common Stock, other than in connection with customary anti-dilution adjustments resulting from future stock splits,
stock dividends or similar transactions, or (ii) issues or sells any amortizing convertible security that amortizes prior to its maturity
date, whereby it is required to or has the option to (or the investor in such security has the option to require the Company to) make
such amortization payments in Common Stock (whether or not such payments in stock are subject to certain equity conditions) or (iii)
enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or &ldquo;at-the-market&rdquo;
offering, whereby it may sell securities at a future determined price, regardless of whether shares pursuant to such agreement have actually
been issued and regardless of whether such agreement is subsequently canceled, provided that any issuance of shares upon the exercise
of the Common Warrants issuable under the private placement Private Placement Purchase Agreement will not be deemed a Variable Rate Transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Pre-Funded Warrants and the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.<BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of approximately $3 million of Shares; provided, however, that a Purchaser in its sole discretion,
may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid
by such Purchaser less $0.001 per Pre-Funded Warrant. Each Purchaser shall deliver to the Company, via wire transfer, immediately available
funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and the
Company shall deliver to each Purchaser its respective Shares and Warrants, as determined pursuant to Section 2.2(a), and the Company
and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants
and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of counsel to the Placement Agent or such other
location (or remotely by electronic means) as the parties shall mutually agree. Unless otherwise directed by the Placement Agent, settlement
of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company
shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly to the account(s)
at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver
such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer
to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
on the date hereof, (a) this Agreement duly executed by the Company and (b) a certificate executed by the Chief Financial Officer of
the Company in customary form reasonably satisfactory to the Placement Agent and its counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in form and substance reasonably acceptable to
the Placement Agent and Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
subject to the last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;DWAC&rdquo;) Shares
equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Shares, divided by the Per Share Purchase Price, registered
in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrant divided by the Per Share Purchase Price, with an exercise price equal to $0.001, subject to adjustment as provided therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the
Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
on the date hereof, the Lock-Up Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
on the date hereof, a copy of resolutions of the Board of Directors that evidence the voluntary adjustment of the exercise price of all
warrants issued on July 26, 2021 from $2.79 to $1.40;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
a duly executed and delivered Officers&rsquo; Certificate, in customary form reasonably satisfactory to the Placement Agent and its counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
a cold comfort letter from the Company&rsquo;s auditor, addressed to the Placement Agent in form and substance reasonably satisfactory
in all material respects; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
for delivery to the account of the Company, or, if directed by the Placement Agent, the Subscription Amount shall be made available for
&ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.<BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). Except as set forth
in Schedule 3.1(a), the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free
and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;Material Adverse
Effect&rdquo;; provided, however, that &ldquo;Material Adverse Effect&rdquo; shall not include any event, occurrence, fact, condition
or change, directly or indirectly, arising out of or attributable to: (i) general economic or political conditions, (ii) conditions generally
affecting the industry in which the Company or any Subsidiary operates, (iii) any changes in financial or securities markets in general,
(iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening thereof, (v) any pandemic,
epidemics or human health crises (including COVID-19), (vi) any changes in applicable laws or accounting rules (including GAAP), (vii)
the announcement, pendency or completion of the transactions contemplated by the Transaction Documents, or (viii) any action required
or permitted by the Transaction Documents or any action taken (or omitted to be taken) with the written consent of or at the written
request of Purchaser) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filings with the Commission of the Prospectus Supplement, (iii) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and
Warrant Shares for trading thereon in the time and manner required thereby and such other filings as are required to be made under applicable
state securities laws (the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with
the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable (which means that no further sums
are required to be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents and applicable law. The Warrant Shares, when issued in
accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable (which means that no further
sums are required to be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents and applicable law. The Company has reserved from
its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.
The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became
effective on November 9, 2022, including the Prospectus, and such amendments and supplements thereto as may have been required to the
date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the
effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and
no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company,
if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule
424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the
Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements
of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements
thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform
in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company
is eligible to use Form S-3 under the Securities Act and it meets the requirements set forth in General Instruction I.B. of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g)(1), which Schedule
3.1(g)(1) shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. Other than as stated in Schedule 3.1(g)(1), the Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s
stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as set forth in Schedule 3.1(g), or pursuant to the Private Placement Purchase Agreement,
there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents
or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
shares of Common Stock or other securities to any Person (other than the Purchasers). Except as set forth in Schedule 3.1(g)(2), there
are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except as set
forth in Schedule 3.1(g)(2), there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption
or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights
or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of
the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state
securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders&rsquo; agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any
of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company is not currently an issuer subject to Rule 144(i) under the Securities Act. The Company has
filed Form 10 information at least one year prior to the date hereof. The financial statements of the Company included in the SEC Reports
comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect
thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted
accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise
specified in such financial statements or the notes thereto, and fairly present in all material respects the financial position of the
Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on Schedule 3.1(i), (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence
or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or
their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed
by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed
at least one (1) Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth in Schedule 3.1(j), there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on Schedule 3.1(j), (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or (ii) would, if there were an unfavorable decision, have
or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company except in the ordinary
course of business that would not have a Material Adverse Effect. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable
rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company and the
Subsidiaries, in each case free and clear of all Liens, except for (i) Liens that do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii)
Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP, and the
payment of which is neither delinquent nor subject to penalties. Neither the Company nor any of its Subsidiaries has received any written
notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Company or its Subsidiaries under any of
the leases or subleases or licenses or with respect to the properties mentioned above, or affecting or questioning the rights of the
Company or any Subsidiary to the continued possession or use of the leased or subleased or licensed premises or the properties mentioned
above, other than such claims which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received written notice that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the
Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage in amount deemed prudent by the Company. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth on Schedule 3.1(r), during the past three fiscal years and the
subsequent interim period through the date of this Agreement, none of the officers or directors of the Company or any Subsidiary and,
to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with
the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary
or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee
benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. Except as set forth on
Schedule 3.1(s), the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have
evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The
Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for the fees and expenses of the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Except as disclosed on Schedule 3.1(w), no Person has any right to cause the Company or any Subsidiary to
effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All
of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, is true and correct and does not contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which
they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Tax Status</U>. Except as disclosed in Schedule 3.1(cc), the Company and its Subsidiaries each (i) has made or filed all material
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii) has paid all material taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Foreign Corrupt Practices Act</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Accountants</U>. The Company&rsquo;s accounting firm is M&amp;K CPAs, PLLC. To the knowledge and belief of the Company, such accounting
firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the
financial statements to be included in the Company&rsquo;s Annual Report for the now current fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>No Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(g) and 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent in connection
with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Purchasers
shall be deemed a representation and warranty by the Company to the Purchasers as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the questionnaires most recently completed
by each of the Company&rsquo;s directors and officers and beneficial owner of 5% or more of the shares of Common Stock or Common Stock
Equivalents is true and correct in all respects and the Company has not become aware of any information which would cause the information
disclosed in such questionnaires become inaccurate and incorrect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan, if any, was granted
(i) in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair
market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option
granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has
been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options
with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>FDA</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) under
the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
<U>Cybersecurity</U>. (i) (x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any
Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective
customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively,
&ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of
any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and
Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders,
rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use,
access, misappropriation or modification, except, in the case of clauses (i) and (ii) herein, as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the law of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the legal, valid and binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no present intention of distributing
any of such Securities (this representation and warranty shall not limit such Purchaser&rsquo;s right to sell the Securities pursuant
to a registration statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring
the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as
defined in Rule 144A(a)(1) under the Securities Act. Such Purchaser hereby represents that neither such Purchaser nor any of its Rule
506(d) Related Parties (as defined below) is a &ldquo;bad actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities
Act. For purposes of this Agreement, &ldquo;Rule 506(d) Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad
Actor disqualification&rdquo; provision of Rule 506(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be and has not been provided to it (other than with respect
to the transactions contemplated by the Transaction Documents). In connection with the issuance of the Securities to such Purchaser,
neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Warrant Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to
cover the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant
to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any
subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available
for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again
and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability
of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and state securities
laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance
or resale of the Warrant Shares effective during the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. Until no Purchaser owns any Securities and the Warrants have terminated, the Company covenants to maintain
the effectiveness of the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to use reasonable best
efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to
be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file, within the time required by the Exchange Act, a Current Report on Form 8-K,
including the Transaction Documents as exhibits thereto, with the Commission. From and after the issuance of such press release, the
Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the
Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents (including,
without limitation, the Placement Agent) in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries, or any of their respective officers, directors,
agents (including, without limitation, the Placement Agent), employees or Affiliates on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) to the extent required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which such cases the Company shall (x) obtain
prior advice of competent counsel that such disclosure is required, (y) provide the Purchasers with prior notice of such disclosure permitted
under this Section 4.4 and (z) reasonably cooperate with such Purchasers regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents,
employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to
applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes
(which for the avoidance of doubt may include acquisitions, in the Company&rsquo;s discretion), including working capital. The Company
shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade payables
in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any shares of Common Stock or
Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with
counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Listing of Common Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on
such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market,
it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause
all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then
take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all
respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company
agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established
clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until one hundred and twenty (120) days after the Release Date, neither the Company nor any Subsidiary shall (i)
issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock
Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant
to the Private Placement Registration Rights Agreement or, solely with respect to securities issued pursuant to any share or option plan
duly adopted for such purpose by the Board of Directors or a committee of non-employee directors established for such purpose for services
rendered to the Company, on Form S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until twelve (12) months from the Release Date, the Company and its Subsidiaries shall be prohibited from effecting
or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock
Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive
relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.10 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance. In addition, nothing in this Agreement shall prohibit the Company from effecting the spin-off of its subsidiary,
SRM Entertainment, Inc., in the previously announced spin-off and listing of SRM on the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the
foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that
(i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, agents or Affiliates after the issuance of the initial press release as described
in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth
above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Capital Changes</U>. Until the date that is one hundred and eighty (180) days after the Release Date, not including any days following
six (6) months after the Closing Date on which current public information is unavailable in accordance with Rule 144(c)(1), the Company
shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior written consent of the
Purchasers holding a majority in interest of the Shares and Pre-Funded Warrants, based on the initial Subscription Amounts hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant
to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive
effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek
specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>QEF Election</U>. If a Purchaser so requests in writing for any taxable year of the Company, the Company, after consulting with its
outside accounting firm, shall within 15 Business Days notify such Purchaser in writing that either (A) neither the Company nor any of
its Subsidiaries was a &ldquo;passive foreign investment company&rdquo; as defined in Section 1297 of the Code (&ldquo;PFIC&rdquo;) for
such year, or (B) the Company and/or one or more of its Subsidiaries was a PFIC for such year, in which event the Company shall provide
to such Purchaser, upon the reasonable written request of such Purchaser, the information reasonably necessary to allow such Purchaser
to elect to treat each of the Company and any applicable Subsidiaries (if any), respectively, as a &ldquo;qualified electing fund&rdquo;
(within the meaning of Section 1295 of the Code for such year, including a &ldquo;PFIC Annual Information Statement&rdquo; as described
in Treasury Regulation Section 1.1295-1(g)(1) (or any successor Treasury Regulation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.<BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded
Warrants based on the initial Subscription Amounts hereunder (or, prior to Closing, the Company and each Purchaser) or, in the case of
a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of
the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the law of the State of New York. Each party agrees that all legal
Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other
Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners,
members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City and County of New York for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including
with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any
Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding
is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any
provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party
in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through the legal counsel to the Placement Agent. The legal counsel of the Placement Agent does not represent
any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms
and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.
It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
RD Securities Purchase Agreement Signature Pages Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
RD Securities Purchase Agreement &ndash; Company Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JUPITER
    WELLNESS, INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    bjohn@jupiterwellness.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    John</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
RD Securities Purchase Agreement &ndash; Investor Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has caused this Securities Purchase Agreement to be duly executed by its authorized signatory as of
the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Purchaser:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Purchaser:</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice to Purchaser:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Amount</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
    (remaining unpaid aggregate exercise price $[&#9679;] for pre-funded warrants)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-funded
    Warrants:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Ownership Blocker:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Warrants:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Ownership Blocker:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employer
    Identification Number: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.03
<SEQUENCE>4
<FILENAME>ex10-03.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.03</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of January 19, 2023, between Jupiter
Wellness, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each
such purchaser, a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>Definitions</U>.</B> Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have
the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, fifteen (15) calendar days
following the Filing Date (or, in the event of a full review by the Commission, ninety (90) calendar days following the Filing Date)
and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), fifteen (15)
calendar days following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of
a full review by the Commission, forty-five (45) calendar days following the date such additional Registration Statement is required
to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that one or more
of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date
as to such Registration Statement shall be the fifth (5th) Trading Day following the date on which the Company is so notified if such
date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading
Day, then the Effectiveness Date shall be the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder fifteen (15) days after the Closing Date
and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest
practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise
of the Warrants and Pre-Funded Warrants (assuming on such date the Warrants and Pre-Funded Warrants are exercised in full without regard
to any exercise limitations therein), and (c) any securities issued or then issuable upon any stock split, dividend or other distribution,
recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall
cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration
Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities
is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder
in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously sold in accordance with
Rule 144, or (c) such securities become eligible for resale and without the requirement for the Company to be in compliance with the
current public information requirement under Rule 144 (if such requirement is applicable) as set forth in a written opinion letter to
such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any
securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable,
were at no time held by any Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<U>Shelf Registration</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-1 (or Form S-3 to the extent
the Company is eligible to use such registration statement form, subject to the provisions of Section 2(e)) and shall contain (unless
otherwise directed by at least 85% in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto
as <U>Annex A</U> and substantially the &ldquo;<U>Selling Stockholders</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>,
<U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior
written consent. Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed
under this Agreement (including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly
as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts
to keep such Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered
by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale
restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information
requirement under Rule 144 (to the extent applicable), as determined by the counsel to the Company pursuant to a written opinion letter
to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;).
The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading
Day. The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on
the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for
effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective
date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder
within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an
Event under Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the
provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the
Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the
Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission
for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its
Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First, the
    Company shall reduce or eliminate any securities to be included other than Registrable Securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second, the Company shall
    reduce Registrable Securities represented by the Warrant Shares (applied, in the case that some Warrant Shares may be registered,
    to the Holders on a pro rata basis based on the total number of unregistered Warrant Shares held by such Holders); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third, the Company shall
    reduce Registrable Securities represented by Shares (applied, in the case that some Shares may be registered, to the Holders on a
    pro rata basis based on the total number of unregistered Shares held by such Holders).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein or the Company
subsequently withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause (i)) as
of the Filing Date, or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance
with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is
notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo;
or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file
a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement
within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order
for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable
Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement (provided if the
Registration Statement does not allow for the resale of Registrable Securities at prevailing market prices (i.e., only allows for fixed
price sales), the Company shall have been deemed to have not satisfied this clause), or (v) after the effective date of a Registration
Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included
in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable
Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not
be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such
five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded,
and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the
Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after
the date payable, the Company will pay interest thereon at a rate of 15% per annum (or such lesser maximum amount that is permitted to
be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus
all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata
basis for any portion of a month prior to the cure of an Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any Underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<U>Registration Procedures</U>. </B>In connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to
the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex B
</U>(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing
Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company), and (iv) comply in all material respects with the applicable
provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration
Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition
by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company and the Company agrees that the Holders shall not have any duty of confidentiality to the Company and shall not
have any duty to the Company not to trade on the basis of such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and
any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section
3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall
suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly
as is practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration
Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing
if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control
over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of
the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
<U>Registration Expenses</U></B>. All fees and expenses incident to the performance of, or compliance with, this Agreement by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses
referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with
the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for
trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including,
without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the
Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities),
(iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability
insurance, if the Company so desires such insurance to be purchased at the sole discretion of the Company, and (vi) fees and expenses
of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement.
In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions
contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal
or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions
of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
<U>Indemnification</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as
incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any
rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but
only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in
writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such
Holder&rsquo;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder
expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the
Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section
3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such
Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt
by such Holder of the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution, threat or
assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is
aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified
person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in
the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex
A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or
omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such
indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
<U>Miscellaneous</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and
each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect
of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities
are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall
not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Piggy-Back Registrations</U>. If, at any time during the Effectiveness Period, there is not an effective Registration Statement covering
all of the Registrable Securities and the Company shall determine to prepare and file with the Commission a registration statement relating
to an offering for its own account or the account of others under the Securities Act of any of its equity securities, other than on Form
S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely
in connection with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock
option or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if
within fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include
in such registration statement all or any part of such Registrable Securities such Holder requests to be registered; <U>provided</U>,
<U>however</U>, that the Company shall not be required to register any Registrable Securities pursuant to this Section 6(d) that are
eligible for resale pursuant to Rule 144 (without volume restrictions and provided the Company is in compliance with the current public
information requirement under Rule 144) promulgated by the Commission pursuant to the Securities Act or that are the subject of a then
effective Registration Statement that is available for resales or other dispositions by such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security); provided that no such amendment, action
or omission that adversely affects, alters or changes the interests of any Holder in a manner disproportionate to the other Holders shall
be effective against such Holder without the prior written consent of such Holder. If a Registration Statement does not register all
of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable
Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate
which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent
to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and
that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable
Securities to which such waiver or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be
amended, modified, or supplemented except in accordance with the provisions of the first sentence of this Section 6(e). No consideration
shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the
same consideration also is offered to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Inconsistent Agreements</U>. The Company has not entered, as of the date hereof, nor shall the Company, on or after the date of
this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted to
the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth on <U>Schedule 6(h)</U>, the Company
has not previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that
have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page
were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33.75pt; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint
with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
Registration Rights Agreement Signature Pages Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
Registration Rights Agreement &ndash; Company Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JUPITER
WELLNESS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    John</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[JUPW
Registration Rights Agreement &ndash; Holder Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized
    Signatory of Holder:</I></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address of Authorized
    Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
of Distribution</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated
    price per security;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex A - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the Common Stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
Common Stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex A - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to
the selling stockholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of Common
Stock and warrants, see &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of
Common Stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of
the shares of Common Stock and the warrants, the selling stockholders have not had any material relationship with us within the past
three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of Common Stock by
each of the selling stockholders. The second column lists the number of shares of Common Stock beneficially owned by each selling stockholder,
based on its ownership of the shares of Common Stock and warrants, as of [&#9679;], 2023, assuming exercise of the warrants held by the
selling stockholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of Common Stock being offered by this prospectus by the selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of Common Stock issued to the selling stockholders in the &ldquo;Private Placement of Shares of
Common Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of Common Stock issuable upon exercise of the
related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the registration rights agreement, without regard to any limitations on the
exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants, a selling stockholder may not exercise the warrants to the extent such exercise would cause such selling stockholder,
together with its affiliates and attribution parties, to beneficially own a number of shares of Common Stock which would exceed 4.99%
or 9.99%, as applicable, of our then outstanding Common Stock following such exercise, excluding for purposes of such determination shares
of Common Stock issuable upon exercise of the warrants that have not been exercised. The number of shares in the second column does not
reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 27%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Selling</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of Common Stock</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned Prior to</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 26%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum Number of</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares of Common</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock to be Sold</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant to this</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 22%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of Common Stock</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned After</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex B - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JUPITER
WELLNESS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling
Stockholder Notice and Questionnaire</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of shares of Common Stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Jupiter Wellness, Inc., a
Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities
and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;)
for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of
the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;)
to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address
set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable
Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>QUESTIONNAIRE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Legal
    Name of Selling Stockholder</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Legal Name of Registered
    Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Legal Name of Natural
    Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the
    securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex C - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address
    for Notices to Selling Stockholder:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact Person:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker-Dealer
    Status:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are you a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If &ldquo;yes&rdquo; to
    Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If &ldquo;no&rdquo; to
    Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are you an affiliate of
    a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you are an affiliate
    of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time
    of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with
    any person to distribute the Registrable Securities?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If &ldquo;no&rdquo; to
    Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex C - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
    Ownership of Securities of the Company Owned by the Selling Stockholder.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except as
    set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other
    than the securities issuable pursuant to the Purchase Agreement.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type and Amount of other
    securities beneficially owned by the Selling Stockholder:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationships
    with the Company:</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except as
    set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
    of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
    the Company (or its predecessors or affiliates) during the past three years.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State any exceptions here:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 43%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial Owner:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 31%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO BJOHN@JUPITERWELLNESS.COM, WITH A COPY TO AMARCUS@SRF.COM.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Annex C - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.01
<SEQUENCE>5
<FILENAME>ex99-01.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jupiter
Wellness Announces Closing of $4.1 Million Registered Direct and Private Placement Offerings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JUPITER,
FL / ACCESSWIRE / January 23, 2023 / Jupiter Wellness, Inc. (&ldquo;JUPW&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: JUPW), a wellness
company focused on hair, skin, and sexual wellness, today announced the closing of its previously announced registered direct offering
and concurrent private placement with investors for the purchase and sale of 4,315,787 shares in a registered direct offering. In a concurrent
private placement, the Company also issued and sold to the same investors a total of 8,631,574 warrants to purchase up to one share of
common stock each at an exercise price of $1.00 per share. The private placement warrants will be exercisable beginning six months after
issuance. 4,315,787 warrants have a 3-year term from the initial exercise date and 4,315,787 warrants have a 5-year term from the initial
exercise date. The purchase price of one share, one 3-year warrant and one 5-year warrant was $0.95. The aggregate gross proceeds to
the Company of both transactions were approximately $4.1 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aegis
Capital Corp. is acting as the Exclusive Placement Agent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registered direct offering was made pursuant to an effective shelf registration statement on Form S-3 (No. 333-267644) previously filed
with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and declared effective by the SEC on November 9, 2022. The final
prospectus supplement and accompanying prospectus describing the terms of the proposed offering were filed with the SEC and are available
on the SEC&rsquo;s website located at http://www.sec.gov, and electronic copies of it may be obtained by contacting Aegis Capital Corp.,
Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or
by telephone at (212) 813-1010.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offer and sale of the securities in the private placement were made in a transaction not involving a public offering and have not been
registered under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), or applicable state securities laws. Accordingly,
the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable
exemption from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered
only to accredited investors. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more
registration statements with the SEC covering the resale of the ordinary shares and the shares issuable upon exercise of the pre-funded
warrants and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Jupiter Wellness</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jupiter
Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and
intellectual property. The Company&rsquo;s product pipeline addresses a range of conditions, including hair loss, eczema, burns, and
sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements, and licensing royalties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interested
investors and shareholders are encouraged to sign up for press releases and industry updates by registering for Email Alerts at https://jupiterwellness.com/email-alerts/
and by following Jupiter Wellness on Twitter and LinkedIn.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
561-244-7100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>media@jupiterwellness.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
561-244-7100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
investors@jupiterwellness.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent any statements contained in this presentation of Jupiter Wellness, Inc. (the &ldquo;Company&rdquo;) contains &ldquo;forward-looking
statements&rdquo; as defined in the Private Securities Litigation Reform Act of 1995 and the information that are based upon beliefs
of, and information currently available to, the Company&rsquo;s management as well as estimates and assumptions made by the Company&rsquo;s
management. These statements can be identified by the fact that they do not relate strictly to historic or current facts. When used in
this presentation the words &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; intend,&rdquo; believe,&rdquo; plan,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;projected&rdquo; and other words or the negative of these terms and similar expressions as they relate to the Company or the Company&rsquo;s
management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events
and are subject to risks, uncertainties, assumptions and other factors relating to the Company&rsquo;s industry, its operations and results
of operations and any businesses that may be acquired by the Company. Should one or more of these risks or uncertainties materialize,
or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected,
intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable,
the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security
laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to
actual results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>jupw-20230119.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKPybP9z5Z8mekhvWBzbRkqzy0i+JnB3y3yW9Y2gSkF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:JUPW="http://jupiterwellness.com/20230119" elementFormDefault="qualified" targetNamespace="http://jupiterwellness.com/20230119">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://jupiterwellness.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="jupw-20230119_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="jupw-20230119_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="jupw-20230119_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" name="WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>jupw-20230119_def.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jupiterwellness.com/role/Cover" xlink:href="jupw-20230119.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://jupiterwellness.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="jupw-20230119.xsd#JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:label="loc_JUPWWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_JUPWWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName_40" xlink:type="arc" order="58" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>jupw-20230119_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="jupw-20230119.xsd#JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:label="JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:to="JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember_lbl" xml:lang="en-US">Warrants, each exercisable for one share of Common Stock at $8.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>jupw-20230119_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jupiterwellness.com/role/Cover" xlink:href="jupw-20230119.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://jupiterwellness.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="jupw-20230119.xsd#JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:label="loc_JUPWWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_JUPWWarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140495729061056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">JUPITER
WELLNESS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001760903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2455880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1061
E. Indiantown Rd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste. 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jupiter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">244-7100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not
Applicable<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JUPW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember', window );">Warrants, each exercisable for one share of Common Stock at $8.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each exercisable
    for one share of Common Stock at $8.50 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JUPWW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:JUPW="http://jupiterwellness.com/20230119"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="jupw-20230119.xsd" xlink:type="simple"/>
    <context id="From2023-01-19to2023-01-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="From2023-01-192023-01-19_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <context id="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001760903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">JUPW:WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-19</startDate>
            <endDate>2023-01-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-01-19to2023-01-19">0001760903</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-01-19to2023-01-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-01-19to2023-01-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-19to2023-01-19">2023-01-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-01-19to2023-01-19">JUPITER WELLNESS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-19to2023-01-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-01-19to2023-01-19">001-39569</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-19to2023-01-19">83-2455880</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-19to2023-01-19">1061 E. Indiantown Rd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-19to2023-01-19">Ste. 110</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-19to2023-01-19">Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-19to2023-01-19">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-19to2023-01-19">33477</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-19to2023-01-19">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-19to2023-01-19">244-7100</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2023-01-19to2023-01-19">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="From2023-01-19to2023-01-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-01-19to2023-01-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-01-19to2023-01-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-01-19to2023-01-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-01-192023-01-19_us-gaap_CommonStockMember">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-192023-01-19_us-gaap_CommonStockMember">JUPW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-192023-01-19_us-gaap_CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">Warrants, each exercisable     for one share of Common Stock at $8.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">JUPWW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-192023-01-19_custom_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-19to2023-01-19">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-01-19to2023-01-19">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  $A#E6JL0B%C,!   B @  #P
M 'AL+W=O<FMB;V]K+GAM;(U1T6[", S\E2H?L!:T(0U17D#;D*8-C8GWT+K4
M(HDKQX6-KY_;JAK27O:4W-FZW%T6%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$
MG53$WHI"/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P
M.6/$ SJ4[]ST=P<F\1C0XQ7*W&0FB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7
MF?RTA]@S8@\?5HWD9I:I8(4<I=_H]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF
M2&]B]#V,YU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMR
MR"9JZJ8IGJ,.>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7
MLN48<?R>Y0]02P,$%     @ !(0Y5B0>FZ*M    ^ $  !H   !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C
M$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C
M,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI
M160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%
MKLWC":[?#'!X=/X!4$L#!!0    (  2$.59ED'F2&0$  ,\#   3    6T-O
M;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^
MDV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT
M(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"
MS&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE
M8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F
M"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECF
MS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ !(0Y5@=!
M36*!    L0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    "  $A#E63GP]KNX    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  $A#E6F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   (  2$.5;D5- R' 4  $P5   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  $A#E6X/0ZB:H"   P#
M#0              @ %?#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  2$
M.5:7BKL<P    !,"   +              "  300  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    (  2$.5:JQ"(6,P$  "("   /              "  1T1  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  $A#E6)!Z;HJT   #X 0  &@
M            @ %]$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    "  $A#E699!YDAD!  #/ P  $P              @ %B$P  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  "L%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jupiterwellness.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-01.htm</File>
    <File>ex10-02.htm</File>
    <File>ex10-03.htm</File>
    <File>ex99-01.htm</File>
    <File>jupw-20230119.xsd</File>
    <File>jupw-20230119_def.xml</File>
    <File>jupw-20230119_lab.xml</File>
    <File>jupw-20230119_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 28
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "jupw-20230119_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jupw-20230119_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jupw-20230119_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "jupw-20230119.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 66,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "JUPW",
   "nsuri": "http://jupiterwellness.com/20230119",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-01-19to2023-01-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://jupiterwellness.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-01-19to2023-01-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "JUPW_WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each exercisable for one share of Common Stock at $8.50 per share"
       }
      }
     },
     "localname": "WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember",
     "nsuri": "http://jupiterwellness.com/20230119",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://jupiterwellness.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-23-002455-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-002455-xbrl.zip
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M/H6=@36 6:$9KC-8[P3FNP*MJN:>@MZ5K3C"4+*FA5W$*!;,,J[?]F)7PY3
M'%1) 2N3ESP_-?88G^<CC,):?G%>PHP6>.W#KV1F8-7J<C[+2Q+Z]#N#<:NJ
M++)5M(:M !]2D!?[N:L; VJB"IWA\ES!B]Q#-44U/FJ;G)N"@P<P'UM34)N@
MA>(V6<'!@<G'22GX(H+=>.=E$ SI_[MW+WJ1F3S]+GJ;G)LGT,!OK2E6^,,G
MT9LMK?1W^"*YD9]$?TOR%K^.[MT3L,SWSU_^S?:2!WRO*;<P"HS?RP?+LH$9
M_B[Z"C];T@YTGSV%C?T^.CI\#/-9EWF6PLC/CI^^.HF>G;QZ]?;X^?.7K__Z
MO_YT_T_T][NWQ\_LW_)2:0]CH<FVAL[9?SV!39,V%S@+]_]CR#UZ=FK;@#W;
MX#ZW"P,C"%<J-VOZQ?, 1!+X/H/7P;-J=NV\/HG.=EMX_W&5++/5D^AULC$\
M]Z]+G-$C_:._V%_A-]__Y>PY_L\I_@_.#OP7)GY@#9:@++^_MS2PP:'M+:VK
M7I>O!M:%I^-MN(SRL=T\;\,WZH[B 'A#_,%S,EV\-[QX=_=>%O/96Y#>YM.X
M_(X6Z:1GW^H!>9 *7-&PJ@.^'WN!XYJ+1NVBX11M3W(S  <8 @\\.#R:ML-M
M'E!W.Z 2'C@$E<%U5B6D1SW72C9*"MD+9ZA6);SPS\M5B]I;S6)DB:@J\P$V
M"\&O8!.E)L_@NF0-&W^=;+<YW)T8'-\F%>ZH^:QA_!.'T_%-"LNRQ7@Y3DM$
M *D#:L2CE?ZSJEE[7<*$BK*)L(Z$W_:N7:(T(]TD.MZ4K2!@%IFT)#:D- -]
MZ30D_>\<@AC%(07@$5T8J\'7\-.:H5Z@A2;PVW0Z&;=Y0 K-EPYYR''A7Z+"
M5H#A< H&8-'BKDD-8Z*^^4ICHJ:EOLT#TL#-35;7W6B87_"?BPP%V+L&A&2M
M+S^4'2<?0/84YR0[I)EIW6_S@()U+T$3?M>4J_?#EY_$IFI\HN-GC*,_WS^\
M?_\([RU">,$-AAZ(BZ0R<G45UG^URI.:_)0*1)@5<)_P;8IJ]7RFOMO ?867
M8+)&//*24&+81&:O$MYRDX"YU0,:WFC1R6]M!OL%U:1AO^<XTE3\;*C&9!)H
ME2UT5;9Y&J$OK\G9?KLH<XF 5@:;*:.$ !]F/DL:>D\#_8^X;Q%U#?48<9O%
M$89AR[:)\FR3->+79"CNLHE1#UN;"A6YFG])&3AQ5&[YR:NDJM J<#[:C.*T
MA#G&T'*$$'_=#]#QR(^"FB =#?@EJ([5*JM).Z0_>=O3W^NRBEWK5QD8*3+X
M>F3T!+2\A*.I1SP=H-L\H-X!^H5WU4AH2/9<".0F>4P'2:^[,D0$/>=M".N=
M%MN(D :K55FE";K3\%C 27:6[H-%<A#Q+HOE+,J+;&?%L;(T-B*-V4C4(QB9
M))E%Q_>.<%!T;P0?/^"/FP;,"^@MFT;3MKW- ]J3$31!&/Y]EGT^>U:V16WR
MOK0BB),D<^&*_WSX[C!:&\P,R/7UCQ% E @N& 4?0 ] R)CB'UD"/0.U\@6(
M!)1,KUZ]C:.CHV\>1\=LEK+R,)\=;Z#+JP3Z_O"H;J(7>8EWIVT3_O5WC#H\
M_&K:7K=Y0&Y[/<]J";3"/8270@M*S_"-Z!^-W)-=G=+?A*""P<Z#S800/[QH
M<)M.F^(V#VAP4^"/>OLA)F]IUL7Y(PP3,T<Y&34A*(7HYP172$+_;Q6Q2?KM
M=_?O1\GAYC!:.-E$D7/4Y0]09LUG'$6,-EE:H&TP_"2^%#:A>DF,C1_M:5R2
M9G6_L@T!3QL#&U?E+*#PP]1?IY^U!1R 6MD,;)6L)#L8;21TY%9YAK8#FB7B
MIGZ+  J:K^-SE^E%7N-],VH3B^T4S&=CLW7=A Y-4U'"==!8=,S-)@UG8S[[
MU--QYV7$?KC#@PG9\'F1#0\F9,-T!][H#ORMA9=;'-Y\=G(9(LA_-\8!P<15
M-8$<;O6 _$;XV]M/ B&?< RW?$!NQ4_6:Z8RV8=D8$VF;JP%1*HA*;OHP\-/
M*,>6 KOG&6A")$4X[$?*3D4?F\K"2L&"1U ,;JYW[&9$54[\?F"<\6<7H$H1
M&"#%( X:6L;VUNI3/G0(:OKR0,,K^@U'KEV',BCSD,6#LJ".'CT"A7T^PV#2
MTNQYR'KZF8Z 8@0TW+6$&ZRER(!EA"+#!WGFW*$<*6/+$=ZPS+,5/(5>3IY
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MPK_4E7R=RSCTB-R=P?^.4/6W4ZCZ\X:JOYU"U9.LVA=V^ C<WQC81G!)B@(
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M\5!_QWV+SD1:QU!@A6NVS\'MA-\U"S6MSQ];'QW4PW2'ZA);PXQ@=.EWCUT
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M,9EQX+AA3A0VRELV/M D@<EIN!\ZP.<R@3#D61;W, !GFBS\TB'P63&QKPU
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M9W3[#C765" Y$*4;D#';;*6*]EV!'P4Q%/SCPTH",'\^>G _OG__?M3991A
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MA-)84!\JZ$9)OQP.YC*E7'LG[2Z3I:V'T2H,B_/E8 AP[^M=O=:;=>%@R _
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MR>ERGIW:&7ANLD<\RP'YVWA$"2U7[V+F& !.VYT71-<X +^='("?V0'X[>0
MG*[:T:MVN91,RA)TYV(E:)RG*CF";$,\1$G(!^;,Z)ZH&TP4C 6B<YY1>6$;
M5K,TQH3; 7.I W25W!=F0%9,:-?AR6)WM:R3C&]-DO6.=6K(ER2)99@.;5*I
MJ"V\('P_"BJWH\MODXSFBLFFK!X[\@Z7Q9::9:-Y &W-/"[,XMQBJ'<7:.)3
MYB-:'^K!@XC#MF3*42T/3CL<'YLW;ZRYWQ8JYZ/>$/HHV68-,_2N0$7:B?+B
MC5G*7BRO+$S)I#9!M$-WZ[_W R(F;GE!08L*-AA3G2!HEW,">=43%* M>4CE
M!SKXZ,Q\Y0.VKPNW41QN84D$^I59OX::9L-;OD@NDRRW28J-SLJE3$K>)C;&
MN$KJBVB=P]QT60&:\IR+=+D8L=O5>L=;I8?"VS&;:VQ7YAETD.Q884S+&KNL
M<K;(G.U-)>4,P^Y995L:?JLPZ]A=6Y8-K=(PG3;9\8^%U6=HBW.1$K]ST: 4
ME<R1 56#)R8T,)UG@P+-]!Q1 L@Q69I=*0X7MQ+<0:EUMF36(746YK/%V,9J
MLHV-;+NQK7GI;/\8=C\V8GS?P1"*(62%8-<Y& #LG \4;M8=T=B6Y1V,YV/^
MG+!GE-5Y4DA*+5/Q\G8(8Q (U:_:;;,2=E#]*Q]-2*BX6Y75:>9CU.AU* Q1
MLW@Y&Z9ZXSVA<6%P>>!]$9%H8?-I)'\<=VS;D)^0,2$HL^4LHO.2_WI9X,R:
M=(@/O ?)BJ7LP !WU##S)25:- )<>%%*25UMCG29931'J>^92H<DV"?(ZP]L
M5.B3@#UCPA(8&'.28+?L?KOB7#ZFWB!1]N?'3+VA&5Z85E;V;NWVI6/+$ <0
M%\:KN!X?DSA;H8CE='8'M #G;2+F+M8S2DLAXE"74'#/Z!!/YPATEHE^6V.I
MYJ ,(=_3&(EBVM/ZPE?K6>=&[H6AVXKZX07V,LDIQ%-?&#"\%@+HA5<8\84U
MY8%CB/2CQ%M C1-[6ICSLLED#FTA1EZKE.$?'$9CLMJ2'7,V3-?U0E\S\T_X
MCOC'@0A[\CXHVDO<+\26Y0AI0BH6V0XIXG7X@(L[M"-,Y9XB$K<1UG9/7*9%
MU@!!;%@3<S!37I^$.V^\?LD#6JQ6PO"5?(C>827-/8C?K(/XA=_V"3MZ*<4$
M 5Y0"3-Q]E*:6RY5S*P'?#[[N2#/%/8"1>-8E4T,;&^,8SJQ-674QVOD\KA
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M,#!&P3A$UC%'$@+Q)4Y:'?D7(@W-J3IZ'HC*&62>"R@BMZQ0?A.<;#%L.!_
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M%QS;=<=&_.M3B>Z]F4M,G$ 2''@3M&@O\@9BW&.F*JT++/3E5!KY51GOC+J
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MG5?97'VCD$AX!CV^L^?QW6T'1]M;/QZ<'[G[//L1K('C#_U4"B8!^  N>[W
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M\4DX $Q>FVO<G$-' 1X#<.W@S;(N:WMYA,]@D[P_217$QJ>3RP0N9CIZ3%+
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MT2_R@3PT+OT^#&I@Z6]7TLQ7,GLT5C+[W&2%-OB6(V)W02A47K"R#&*)^Z"
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M3SEL":]WMGRUS<R_7TMQ+Z5KFSMH,*-MM(+_ZD."!=VVHM[8!=VXY%P$E_;
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M#ET;3*W+\+\Y@?O( V*O::^T'4:O.M@A6)JB#%8Y%I\,S65EEH8J&CF:F?-
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M +(E8]Z/<+Z7"Q6*C+:< ?;[Z>0="'&YU4OU:[6O[8$.YQCC\!D%HWDY.,!
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MR$B1@>G*5'X1@H*9T:?4RXQF+"04@0CCGZ<\5"(7@Z_#D.=[C>P0^X;GO5?
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M0K1]M@^;*M5E9J^'<DPZM_:.&]GE[,)1-9Q909WB5 .O$>'!YOA*\ ]RO,#
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M9Y(<XR2F/V(L& N+O3!D =H(7M8,]0.EC_IAS6%F4H+QVP6!X5R8@I %E!1
MC8)172RRM74\*-<%)@QB'=\%^0] W;_B?"(8I#J;8LQ'0']#UJXB7XZ=_1Y+
M^T*79L4"3Q8S)2?P\"Q%SP)F/4-^-<M52$=$;5O);97;<%#TKJ[+(KE*0-#F
M+JIC[T\B3;<;*'8!&*I?P^7TK./(SQ$&[E/K-)&(%4S($N6XIDHLJ\*C"IUG
MQ<8,7?U79I&'B]D=;;BK0OJG>W:=W<\[>BYW]'5A"]5MNY>3!0(_K&]8T^S7
M=NO!=A3U$U-];"DW[305;9,<-H4]*7Q8FBCOV15.QX=ZRXSJ8NPBVO3%&T@H
M.P>0<YK31L2]A>5.NF-9MU7=0FODF$J" +LO]1CR?0UY3E52J "@R.O4$,.:
M?QMN]X.=<\TA0M7!('>,TJZ(8JQBKRH["XE26:*.XR[<@T'-%KP+O0Q@++05
M"^]$98]U+O%K,H>6EBPV(("&'7"="/IEV)HC_8(? /'&6,-T0M\[.DUX0N7L
MP\84>U2:EUP.UMB_%>>TA;S![J<[D +7B'7PB65)/]GNR<,CL!=F1P=P+R:8
MN07*!_[CD7SPE?SW:_GO-_+?(WB2( 3X[T<'6Q/VA _[P$/R!$!/?6#UAJ$?
M\W9C5$^Q#%K8U:/'CT^XKUO?UMO3?7.;R^R)L=-9U@ZE KYU.N&<MNC,L/+[
M3FKOS-1DS@T8W%(<5T8Y3[ ZC)I[YJ7B^+RGI5)9<X2#:?.+)"1J/%<DWS3"
MEQCN;BM&BMBZ1:[*EDM.U"WKOF]<A2@ZMK$OJ.IRB@26Z&);3V7VA:F*U MX
MKINDZ H Z5+UNA,]#G!:L'MVHOP:M_J7HUO];MWJ7XYN]=&M?@_.C7T?%)SZ
MI%Z=?L0J8\PSM.S<T$-6CX,&)KF44K.I]]Y/T:DR&I.A0]>Y E'7Y?H2O9$V
M&QPU+N,[ ]=Q !+T1#*V($!="D9MSB6$YYS;:JNEBDVV@@;%M59E]0>G\UE"
M7W0-L"J&-S0Y1;M*HS75X(72N&B60VW3,'V#@X8,]I3ZG; :819E4:ZR!;4B
MR!G51M3K$W,>",[0FH^4#ZG;3Y9+1-HG#M\>Y64]V,E[)MOW<\,:6W.(>+E2
MVISW;(SW<^&6MGPO^M9Q8[[R:)U!QU*_:&'&A &7B9257F.:3%M(-*0R5QET
M9[O?WV,8X6@!P\)\)$ R'UWUXM*D!$VC&$93'G@\S^ES(=FJW2G(:&PZ6I#D
M4#!1G1XE<(X%Q23((R:CX HQTXD/-E@4(8V%$DS@S_H:3WE$C\7]XN-ATHI@
MENV9S_YZ<=0RZ-#]Q#'RV(J]X:FZ]5R7U 1/[>-_)^#"Q*UO@,::8^RH"Y;"
MYOV-YGJ)($$FG2<XK,/%>\!\',#H%2&@X,0$_%ZWR%*4<>@$S$:Z$C+^0ZXP
M">39.^"I\G[3O'16M)P3'(VK9Z;<W0[PK%LT'>O-U@@L9\9(M&7)A6=<X=.V
M4 @X@S+%E:@_K@D2CPU2&7@O*02-^V X$BK@>W53NNKL0T1F.V[E8,>1<PAM
M]M AP6['+D^"=4N<=*G<NP]>)HI$INNRX@(68?$6RA&[RA9A.5=RPG:T >Q#
M5MM;?:@%M=4J*@]78<4(S5QY\[AP *LDY?*YL 8UNZ6[WN>ZBWJ0?"AR2/@4
MG(%MU^V"14K[+OCZQBQ(E,+V@ M"H.K6"4-WUM^Q89 ;K[,$LN"%,:FM=>Q=
M]()Z]AQ B#0.^%X&E^C716D/#N&"&*1O0::RI/!UJT-6M4YL$<_7FY=7O&F*
MCY3JI#//([K,_"F%HE0S*GF9I>TBD_W8B>+>L]O[?JHD%Y+$ 1<)GNH!JR;G
MHGMPL8.E*)HDA[9P5^Y645?,=YTM1U5G")YM,Y(257W1%</T.1#L7*58E,T/
M\46_\6G:*=T8^S"?D@<+4"*)JA\IJ8^J4K<N:A^[6E^*DSC41OJ%P0GT#;L(
MD3?N<8I=^)+4KL?(G%Q) 3-.M64VOOK2&#ATD)6G8=ZHLDKR Y]6V\WQ8W@;
M3Z<[I;NU<&K3-)+1):>,19C#,:;K,=UBA4ETA!0T6V%0';[/-R%_D ?&<,0%
M*R(UN'!N%?$I=.U=E)@FYTQR"_M/E A9>H,D6H'6E#U@A2A0":X,'/>YX51R
MA'Q@21.\3%"]699Y5HH:157@\1_A(RXO<4OH-.$R*O82&VA54F=$$/L<J0/Z
MB]RT<DWTV\0"5H7D(],RJYYNB_%R1VU1I>#2AB]$ $!=O3(2?BB+G/$+P[RP
M\DJFU^9)L-._K=^\7C2T+0,/JJEV[K@@[*'C*G(T$;,:M:!%OQ:H$/5:_TJ*
MXFZ+B'=]6.XTB)WZ2B%U@<E0?%\J!L985D]*"7K46RRY_QY%(S=JF#)&98)8
MGORM/'1VZJP2VA_AF<U^)%A&S6+(4U\*QJBO8U Q0J^3='+?"#Y(WCF2=G\Z
MA#\[Z&UI5IW]GB9$!,-XRBRU*DU:MG.Z## 8=Z&J/#(:5J12 :]Z-48QV5V0
M#UPZ&!8!^L\TRG)VQ5($5TES7B[X)B,&Y:JB6F66DCXK.(.+;"="-NGK0(/>
M@A-2#JUEBXPDGX52=$,D[:LQDG:WD;2OQDC:&$F[!^?&[Y.=<)?=?H_^,.>^
MV^4JZNM6=;=:,=R5MM[9H\-C!="CG%?D+4?:+ZD.:!;;('O3B</L5:AC"[2Z
MFRC?[8P"![)*U>U;H![U_3O=%HCRVS?A[8Y!&'=@F:3J4T0;5?R7LLN(ELOC
MM;=I+*[+Q%$AJI"8IYZ];;?],M_<9(=\FLXRG=RMTM+3P&^ELY GZB^CM/SN
M^_2/.%[X_K[3,_[9/T[.WK]Z_OIT.GGUK\/OGIU!O]^^__[T+#KYY]GIZ0^G
M;]Z?1V]?1O!1] X?/3W_[HMG=WXW_-[CO$?9B8\/C\A_)LA/V%N)*V?_BK+G
M[5$G1C+[+>SCF:;91XHJ]@51>DIC">HPM8L3*2AY81!SC6DQ"U<>RKN',:_>
M<GWC-V$_Z< -OPAZ=)4EZ&RYI 1%^W$\U!"5SD@[ /%"TFI<-6Z7L"B/+X4G
M"S]%4JLBK7G:F*R+YH+S)!7IB@/HXM]G>CK.W73,+"U,W<YKTH>;;3/''QOG
MJ./9VCUO!Y;\W:\+!U[P,\74Q:DI"$^U5\9M6@]IYGG.M!--T7<C=YKQ5>$L
M_EAQ=BN_HIX F!DW ]+O!H7.#\BELB5+(LJA;B#X==WX/E"[MA-6:K?--(J6
M;QYSG!CKXZ8I^I19BF:9Y9@2UZ_E8R4U+/5JF+NY>SD0=(ESZI#C^;+SCKX1
ME-+8;F#E:^3L"%=89F@__.JTA^E$\A[>]X0 6<'FIFXD0$JQ'F3/W)Z*T7';
M#.^6@]X>L.<'J5$[%\$OJ/)UDY.Z(Y*?A>-C7^\PSK!_R?50!!+1@Z;\"&H^
M;AZ=@WI=<*AF((;KSB)R>G.UF(2H=D.\QI4IZ#%%=<-.0B=:A/P3<0KDW._8
M%<ESN?@@D'QK5QT=S^94;1+^<>' [:<?H?\%&/J8^2!H$]Q;"H* VVPZ4?L,
M[R(X]Y89%B?"B NC(*@B36U59J>5*T( ^H5**U#'P$65+&QDZ( N06&]M33"
M*=WK<T.-]-C[^&#NWHHZ+M8;+')PV1N_4\>$CO\.]_5P63YW5.JF/XO]?8-C
M\^O1L7FWCLVO1\?FZ-B\!^?&ONH%CT@O>$7T<4H3Z&NF>(&P2DRH2BY*)4J\
M%*?B;QBF__^W=ZW-;1M9]KNJ]!]0LX\2JV#%=JS$3K*IE65YHAE'\DKR>%-;
M^P$D0 D)"7 !4 KGUV_?5_?M!B#*CAR3-+\DED0"_>[[./><^<(O$BZ,?=X@
MKDM=HDR'*&1T4/#H%4;*'?^TNV:-%0^(^F\H)'B)ITA(C;5M;3UFW"KBRY:0
M-UY6"5K;/Q,Q.?I'@ML5HDM"/F* CEPGQ^OMX2-&3" DB7P&F;DP'>@(HFO>
M^2R0>1P*C2AIR'8]57G(ZM%_3LAONQD_8#,^P\VH5B>J[[ZR.?WOC6$^Q*VV
MZ-NF>\E C$CW/7QS3,XNU)@" S1D$C( 7C!DP-;0? PB:+@@3#>8XF#(QMH<
MQAB/-7>Y<=JP!)D0$H!N&($.&8[7QC>)GC_Z.X*"M(O;PZ=3.Z1[0]AV)24&
M#H3I/BS[Z#5@J#"*8*UK#;9D 1,U1#&="C+0NH:9MK&26).3@&8#'2."K$ZL
MQ&26>BSFL<*U>HA>EPSQ^)$]#<L/H,UW?S/?R"M%:.RP+)&"LEB8"G[S*J@M
M8&1%B(SI@)\.^@0*/PXQBX!9 :7'Z,!Q+^8SSHO=8S:C>V7X!,'/61T?<>/2
M*A[?KH#C%O0D*@47!=4 SQ>;4[NYS3(OG1<_V!2"4$@X;9UXIJY9"Q:  @WS
M*$-%X#75IC%VNT709ZF[;8L['H,#0P^B36,#"<2MA--8E*#EBA]%EB&L'%!Z
M S*=#B)J:T+&.1QC5%Z0>5R!+E@-655&H/KA1 E>P!K.+-51F$?KA8?ZC4/$
M))),A$W '.:$*'!)JHJ&)2]P,0OO/L/_]&JN.^%Z]SJM?="X%@SP8Z$<GJ;+
M0P+^_AU2>+8>%VW()^ED<Q%+68&(&@1K"//*-?-&>3LA[!N)#^@WB\**@P"S
M"(KWADB]( OX(EMH_LZ7^,TBFD9^IK./58D+<D/!HZ^S24J%&)-D ;$Q5CO*
MA<31W=*YBPHAG=0DN0U8(2D4Y"YL0CL&@7NN7%"[BSZ&':7A**RL:/<4E8&<
MS_[NSI*$>3N? 0/2NOKP<T4R[9DX.J?N^!0"A%'EA62D.BYXAV5P[.E70'<&
M?_"-][ACI<@1K59,B\A-.-F202!;K:T<R0#X=$=]EZ&3Q8(BC$F/D=/174JP
M@.'E-^6.Q<5$:^WQT.Z.6GGXJ!$>-NUI!A$(<D) ^"AW94C  6<^F6%K@ ?+
M>(\J5=7=M!@%"O0*5K=)_P)6#P-!'IC!U$FP*Q2.L;')4/WG0.L1C$JJO\NZ
MJ@J@=5=)A>,4O&V#?:@E@= 7VT#HPP9"7VP#H=M Z-J>%NO9E6?[!Q1Q4<&U
M<Z(I->X0AT+-_AQ-DGQJV=ZD+I8)3SLD4E7@H<^R#8NV8BQH:0+3FZ!!3N'G
MT%)0TK>4O$_D'$]D+"TG%#.D\MF:W&5'LV*NYB$X6?C;69E#W=@L!R600-S2
MDTSD=PB7J_5P!QX?L/&1'S7&!T"PDO$[R"2#7#'7KUMG"O[@ "A)6L[(_?>$
MX5AEL34X(XG[$L< VC^F85?LT"BJ5HDSHZW;;D\,,WB35\T<+0JJQ<-*%A6*
M<T1PW:892+K9&>"2'PNO[7#S726TM3,VV)I8SZX\V_\&SX?3LGA$D=<V9N*8
MQ6L[O' KWW,71\6'1,%V=^QZ$R?4AC!<<%'# Y3=VX?*Z&% B'*NU6V5EU*U
M[NZ.^2<2K5+)KJ@?HN'N;U1FQ.5@%/J6Y UT4B%@(QR&NK8BJR[^JGSL29[=
M,#+=?<$.?'=D-8XXJ<*Y&(H6AU5W*H++AS@EI2SJ3@ 4YK2863_19R906#7U
MS98\J("\6J0..NCX 8&NGBC3IPUT>=YG2 \26UKC/QZ8IG74'Y_DN#G!EKJB
M[/X<(<^Q3\\!$8&>4E%>"OYFXFKC_CW5M;2P')X9+K"0G/@RPCBSSV?Q<,%A
M&<;=G9YQI"=2N^[9B#\^E0A'5'.)L"6XU]'FHD4[3.J<))UQ6)?E46)%Y2&K
M,MP9(#.=:VR4);D7+O>N]9U866SWBI"SH+,T)CS=N))$G5S]R]7%(CH2/_Z*
M: =KC(DVGYA#(ROGM51Z8TA125;@H'*W$-FF?L'EM$' S>OS'9F\#SW![HC4
MX^WSL"?81E@L&V5\?8O&USL*P+^MRI&Y1^N^Q/=<@LL92B;C9QU=1@_ZP[%9
M  Y$%#6L'(I%AABOB,RM_KHPY"N2^+7RN6HK91F6ZX'%9@P/**+7_".@48OK
M.9GE37#M[^ZH9$.=22J&>OL=)O\=P+[)ZW%BI7R" I7.!F5#G^AHEBQ$SH-.
M8/,+.!%KR]/10;[?]62/W9.L+BOH"#SF0]?N*DO-;:!;S75NYB</!@QY(^\7
MQV;,;\P\XXVR-U)#D37-Q J3X'$Y;VPBP]RR5K2EBH @V_3-4UU_??3V$/YV
M]OKP2(?(-_C(N#OZ^_7C;?3W0:._7S_>1G^WT=^U/2W6LRO/]I\S^-47?0)C
M(]"8O/"+)OS08I!@?.X;WA@7$5TIBOI!I#DP<"F+"_Z4\HZ<RZ30G^ D9--A
MYK,-.1^.7$^"_5A@C@K?<!HUB<8HE@7$GD"09N_.W9VJG CW%@5\X,4V^6G\
ME@DY9AX<((GP.!?_ 3_E4P#@KP!6A!VG)]]>EQ*MKEO,:'O=2AVV\.>@&Q6,
M(V"1PX^[*H(&L8V^+A]N05%UC#MF >S(?]1P1Q\SVJ9)]QQN^PD>9009S+AE
M>S 5L9-*\01X4*)$Y1<&D1F4*8;-Q@2@7'!M)U3V(OEK;'4"*2#A8'$QI5!J
M42<'/ 9^)DVF9G3Q]S7'39@0UN/D@W?\.D^O./293$%6"\B^<@BL&:O86GCX
MJ'G5J >JFJ_$F!Y5D2VL*-U8M@Q]W''_7JE@I,T=!*.#)C^P[V*,$V&J\XJ8
M-(G9EWD,M9X=F.CP/+BL >8UULBY@'XC5MP;L8HNE2JUX)/'63>AD^$CUXB[
MSBP&F>*.B\(J P%FE24+_?B)J/ P+ >X^4<YD5O8D)_YQI2#N'Y,2 >;0#X/
MQAE,>4[%!>6Z<%AP)9OQ33P.WJ[9Z4%V?43879-K"QP?J9%YC$ M8 *E@\,$
MXN^(0TU<$-I--06(@W;VT;?HV:<@D<S_/5)1'O[4):?D *E#AD.UH#$B:2/S
M5$"@)X4>;AVDND-:DQX&'<;*9R"1[01#4;B/4Y;IW)S=?<]B-2XBTH83U)P&
M.3#5 K8L(\1H9K5AF7UE7"7S-(ZN*E!"*+(K<QQE3)D M_)X/HFFQ@>G5P_V
M=W=.QGKMVYC3L"KG0+\C.\#/;E #_:H6;B[=^CRNYD$U/<>OW_1%HSJ72$]I
MOMX<+KW@[C8_0$)%NG#*")=04M?S*6,*LS&S<%.)*<P_)%4H3\.A7I T'%V7
M!#U461@@0Y\UHD31/A\6^]%AQY#U-8MN5$O,Z9K!9XS>>QA/@",(Q!>IN*BC
M.Y#W9J( .>_EEE$7)+W$*6XW'/#%#R*&N7-I,IZS:<>'A2^?.D0D'CR^EEQ?
MM$QQ)?L:O3W3"QEZ?K#-/X#8>((%Q)Q)UY<>\]+"P8<LM';B"<S&0\5%TCSX
M=N8K*Y+JC3OV ^C:;71+O;"<Y04;TOR<6)^'$.B=Y",,#>L4#4.,=:Y\5E(0
M+;P*' $K_;UW=KKPL_ZVP)AR;8[L.M?\%*H[G6NF*$$L-Z,X&4#A:>-:-EGN
MN!^I1%^ "<?!5&+IEHZ]H:"+[@H':.28#TP5TX*;,WR U$5P*5P@2V"OG$[(
MJY]:YN9ZT.8.7//WN%3^&:!0S6*%G8?DLAT;)$'#D8U#,0;A04YO&A P#0%0
M[A@O%VB\CUFUN_,A=E7GIO](^XJ60Z R##H0NCC*]R;=,I4&T7[.1Q*>M9D,
M,HOM&:/H.OSHK&_BXASB&0"N#G.^ 5. F0'CE0&$R+)3(VX&'C"")$_J=:?Q
M+(X>0E>LTK3E.S*;HV3.4'Z&.2@T$5T+(0Z<IT';I"H5AC-0V[H4Y95XGY1;
MV3GW^F;^% K.VY#-'PW9O,"0S9N<Y%F"G$ [-\29><G%$PD(H59\DATA)L$%
M,I''5Y$Y5IHDN(*FL$0Y"5&(':YA]%H^UNSF$65$)PM\<,854Z!C8__@TJI4
MV=&5O"5V;EB9YBG2MHQXGR420JD2>'Q( \;W=]!25I(ALQ*-\\P? 28X6_YX
M]BC\Y_N3(15<-!MQR%*"&7>:)6L4>@D>S$&E8C;88U87=!B3A&5Y&SC")!]G
MK1>M7'^/?M%,T?.@J$D5:8L!6D>A9@V>9O><%E*THV5AIS2UL]751Y(;YRF#
M?YLK%$R7#E,#QL XOEB.!0MHQ @">Y'[[<;0S-Q? &AI\?O9#?"S<.#J=BPJ
M?#_R8^%EB7@7=I#J%@!*N\#$1A-+08PC4%?A).4!#Q?@1V*4!8OV><3O6(80
MSY/3P-OUF7E^SF9'%^\0F%[9Q'2@*@MS^V($88S-0/\0O_ J0Y,4BHXN*W,F
M^@ -ZH@Y><S@Y_4UU*B,)EE2$7R!DLY$,']WO>9P(61%*D,[YCXM:X9:6$M;
MTE6M1'Q_[7'8X,MR23;TR38;^K#9T"?;;.@V&[JVI\5Z=N79_I/'5 SCV&(
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M<"%V])0P*7G* N]14&"/4E *>]I7-39PYRZ2FE+ &"!P%MO$"$+X272EA'\
M2[-N$ZCR0DWOCI=:5*L*HG:@BQ@!134FT\SO'"JX)Y.ZM&V$%[M(^(SA8FSO
M]21)7T/#)^94L$V40AP^?UQ352F=Z:##C- ]= 6Q=FI$4% 6$JV;T;(4M:E]
M#F"Z%BW&,#1+:J2;+5(V<H.[M($5P2+RCD<(H8&F8UP(XPY.1K;<4D(2^U3-
M294[? 2=5!27'645^2SPW*NJG,^ZZM"=X#'47M8.4U%%-Z4]C%1=G.)RVV"/
M?TE0]^DVJ/NP0=VGVZ#N-JB[MJ?%>G;%V"DD_')$)JN^<.D..O+I!IC3)+CP
MZNP&T+L3OB?-A?6K<08\W +7/-B+2N.JB'NUBU?$@;CY7O,Y18B;W8MI>3!F
M>KUD_%E,DFP9;D@MU.^ZG,#8\4X?,0[ 8F%*6H79%*"*,940#H-2!DWJX33O
MI3;(N2*((N2"F881$P3*%&:");AT_VD55.B;T7 \F\[K"$5B\B*'.0Z839-Z
M=R?-ZE&5#WW*_6?[SS[).N!XD.LYF3C&5/K CG>P:@<VW7U'(+(#@'43'F5.
M /[#=>:!!MI"[+P([J6>WJE#BE)R3&K X^R76A6+4#2][?2*P "4_8#OZHU,
M]CN.P>1N^FL &@]\-2A@]JTY@*XQE;968:$K%01]9=41!/Z:%5=P@]U)U$ @
M5R>9%B* ;;;BS]T_0'+:MWRB</5@SL$;0(TY;JI\Q+"?WE F#D/'T #2N(?(
M C\Q&AFSIE.8+JC D&*N]*-&%#R<AS^2>D<4VTEX=#VJ$B9:RJ4#4%?XD\<J
MPQNY?SSOR\!CBUD^G&(_5N18BOVF6Z#@X\ZRI9+'<J EM=0C.C5$W,#@9 )]
M3/[(F!ZFO2D#B7'B;[)K,]NH:XI[WGGB@.@:&^<'T%;PM:KF?]C/""^%*\9H
M\RX9GSEKG/1<QT-Q]LVRH/&-[+G&0P;C85N;9B.NW]75<WTM1<,$[[5[-S3F
MTY</0O,K&&JHJ4F&YI=\#B NGH*F7?QQ6D^6NB\#W]=@FBGLDP-Z>SUFE#,V
MFN(3RO-'>=FNHW*#PP#KV15CV)-RTWD&V=0LW<(S5K K9I9(TD<"^T=8@EYK
MM4V;+Y5#-D1J9!#)!*3&\Z5(#8PD>N2M\'$KKVSNR?SW:.\;FX)U#V+8.3[(
MP=<9GQYUB-/D$ AVLKX=-L?YW/S^R;-G>Z/!WI.!9X!Z-$;@T!%$V9Q_P-M'
M!:-E=0L0!"P]C6ICOC142HWA4R]VW0+JWHO4OPF4=*3L'@K5?BVKG(I\(,8+
MIEH'DOMME3UZ/<< L BAQEP!+#HT?$F#E6 N90)A''+MNJ6>VN[:%>N*V;5$
M"WUHG2/)[;S*)_-ND3S/D;*V<VBVJ;L6BH^8)<"LLY0?+!]4!%6X63JP!I*4
MMU]UY4SP55QYA),?<?!G2O!\QT';4Y[1ZDJ.BK"=^/L>&H$E ':L)K;/<X"P
MNXLE6FBJGI>#$V(\#NDFJW GP[J<S%E5"-4,7=V70RZ 89>ADB$22<#VE^I$
M*'2D,PCJQ7/D["8VQHF2+Q9B:T4Y[2:7B]V13CRL1"/OI;/$G)4(@S?18P'7
MP>]T5*-VW=D'B]K2+?"67.<SN]!PRE6!_Y87<<6[8HXG8J5^8^;LT;N9L])[
MN1$1FP$9X9@2O\"-D:!76GEJ6T$.6$5%V^^R*CB06X6:7G+,M##\!+XTGTFP
MU*4\F3F?+VC-I82IUM;+NLP+1$U!7&T_.AD3U0C)'&&FN_T(J@SFZ)7?S?:G
MN\KO;,U57PEAG66_F<.:"_JAUV@NJ>/?Q@%QD[;>NL%;;4FR]>MMLO5ADZU?
M;Y.MVV3KVIX6Z]D5<S%_NXW)K'I7S"P1[>-_';^.CB<4("?#Z<2/>M<ERM)E
M0 RGU!N$@:5)?L?0QR)+0JJRV/^!PBRL\:G2UN!4&3\/!3-&Z&S@\_-J*E*H
MS(#XY"!Z*0S*KR"DPP100792BU,@ASHEW/<.!W<6\91CJ)H/(.ZWB"EC8L 9
MA%QN*%M@YDK'E4>2+B<1HF[]]B=/7WSKALAT=X\?_/;UR9'E%QP#91QV"884
MB?'W7OI$1\:$_ K@:45&(,8JZ\3G4^/AX:X A9YIV8"R&R[H:5MY0.2/9FVH
M^V@%AA4YD$26>*6T$P,QAX(T@W]W_7T"8;H6"R:8UQ-)"@"J,!*&FQ"_:#D4
M*-'GC<A>CN;\(%8YJ0DL337+ &4UEJN9.GPAKD7CZ//\+.?C?/KBP)ODUM#;
MR&2DIC\Z+ K T"IAG>A""K*\9:436X"XK>=FW,XM';=KR#XTY=&3O2L(/%+5
M!;GB,-@H>MGZ\F![3J]85\PY_4+=IC;:V^9[.701$5=W% BT)) DI5NYAQ[/
ML5^4\E'\) CS&/?21KJ!M@JH-:CUXXI*X6;@PLTPTTO::,!X!M2@^2B'@Z:8
M W7L'85#@B&6.CGPA>&,"(0^\#R@6%D0%&N3"=X50I.@5_9[5HUR1PTED>SM
M=EBQKCS;?TKEV<<R8RB(D<ZK3(5]X B%J3RU\KCVXTR%DTJ>7V;:Y:8I1%$V
M'I!I9M^BM*G+EM![#L%-C F7;DUY"PKJ(*1:QQSWD^S*_)>9 F,K=^[N .13
M Q@\(T\4<J:_&<';\TJ]_[V.0UL<'U";$=TR^-[&1ZXACV9>_=NCTNQDU&+N
M&,U6:V*0<Q)\#X9TL]3\$WIR-4^P#"'#JXBKA8W[#@]T?R-18W-;_Y,N) G
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M!N>=F15J[2W/",;VX&W&R\XPX&_.3>@':O)A71K,!OP?\3+=/#B>+ATHP=W
ML46?T6,DXX:A/V- 33).5B#:4R9U5F68YL@HW%L+*%UKQA(R93GU#1XU'<)R
ME5V@9$P6/CY<:,;H-E2,IITRBJ[JRPS>O.(H>S?)8J#X02ATFI<L5<QI/,"0
M#*02)JUPRJ]I$2;),D^NKJ#^JE&H]UF%Y5])G@:3YC(2M2T]H6P3'.AEE7B1
MS38WDXUE)R,"F^MGZ6*LGN\+H9NB0K':(6SH5]G,XC,X7B?IAQ%VDM(+&#7F
M\30-SWB5;+F(5JTK!Z))=JXFUH/]>X:RGFI+R4B%"&[B QH98Q]-C;LV(>MP
M4M8-4->8 Z>@ZF?SB'*!E(GMJD/B-H445X*6(QI2^$N\@++?1RBAQMFC(664
M\,PLJ9 !3\H1+. )\P)+&FTO.(BXC4"V2-J=YN^3/)M'ECE /1X?,H:JK,1X
MV;?]XQ)'PWE#]&C8%*EA!8R@9.(4 W1M&E"/$\C.+]!;\"HV>>.;(:1TT+BQ
M(SAG>_32G9$%Y>N6-)!O2<JOYI6Y',$(@ 2?*Y;:W9E)MLR9Z0C%>D0>.69O
MU+$1C<SJ->NO @2 N7,*XW -(%]<CG*\2%U&1TEB\8'AUN$7$<)?SZX<B"K:
M.:17W3'A9R<I1 4>3S/A4):M&(.:*,*T>LP&2%X:72$-JB1:-5LX%(]+FB=-
MIE!X'7,)4QN8%]IX2+$WS+P6=2KT+%$THWUF <D0#(A((]M8%UD#ZY[;9D''
MX#NGQCR!#8C1@:).U$FUP%WM<:717A, !'/]F9^T$1IH?F?=MFZML1W<6JYX
ME*QZ"\\AB5,T27I$C*S5I,7;,!5',"@:$C :S!I!6 & L]#!U>.QP9M[27[N
MVVU^[F'S<]]N\W/;_-S:GA;KV94#42!\FRS8;&NB0TB:<9ZNS8*B[^1I\AO&
M<V;\;62N75@^4S\ =!^F%#3>-<< ARD1M^HB2*JHIK& S9A-?<S%M=LCJ@R$
M)'+:?1[8TKV$6L( ,>MX)%6F*O@1)*NBYT'0>%PE<Z#^XH88IR.#" 32O4!H
M/X%QCL4J@@*#J@1UTKR^*BO2AJ=65'YT!(,E8V2T@&]C,$(XJA#8;QWW5EPI
M,IY#W63TUHP8!ZI6N8!$WPJTX.['KCI,BM^J^:P9L=5'@%V0?V:\+OYV1#$<
MQ'F;L39]:M A(1<1!GA$7AQ%WQIO^2FK!8-P-JKB ^DBYD^VDR9)/IPNKN6@
M8227#<"7*@QUDXNTB B)I+VI%F,AN;2CK+KK)'5\U5-C*442&@K6FED$Y7AL
M/U^.R(#<8)MJ/;MR(')P)^8-LPQ?8^P7HOC0+"4"D#Q39CXL%HS6JSJI /49
M5!RZW==]1.(AA.G0B74!?BWSHG&N>0<]1L!M$?-7NT.Q]0R@$R('#]Y7LG#"
M-LZ3P/,)<:1MB=3E;5C2TSL@PF7EH7R[:RYL%_GW!!,).?/=O>0*,!KAPNR
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M.@O/DR<8KBU N^>0D1&;SLF7,F..7B"+F=E64NYOZQ"M7%<.1-'S IR@-%G
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M]WS$_X<C@/_"Y+3,TS2/U*=GTPAD._1F19/KSMUWG?B;4W^JY6/=_JG?HK.
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M=DEY =AZQZHQ=A^%!<74>0#L6,4O;"\1$,!X0[MQ)H%9<NA143ZSLV_?8UN
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M-(47XKJ(4BQ6/W%K\74@N8L-L=+QZ!K!4DQ=[ /3$]$,HNG;P^)R&?>OU81
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M&T? 7#6)I-%'7H[(=0^7G0%$&-!Q7D;E(IO1PT[_Z537H.6,'' I#ON0@7R
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M/[&)Y.PH0FJ^VIGN"AV(02-21+K=BX"YN @MB(5B  .'I,4VGS;P"FU2:#Q
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MA=T0KMX8FRV^>DP7XQY#?M:CE,F_6_B-$<.^J:?:]HB)TYD-ZBF5(AZAYWA
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ML%(=(^"QND"*S76CDFS;!H!8;:D $Z2%#8UQ3:M %9;Y!6Q#V/P%;QSB&A^
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MW,$ ^VAMST]*1C2P25.S('B;+I(:44/4(T6HK\]U=JV2L[\A_7ITBGCO^"%
MO$/]*MNM8]\9V_\G!+1[1_."&G?[[=;>BWYG>W>W\Q+)X%^-[2K;>V#$/URQ
ML)>#6 X_'LU(ZW^]Q;T=]C[^]10\/%8\$D,"FF<A%/YP43]<U/^/BZH3P-M]
MU#_>/SV"Q.E*CE6[]9NT(R305U7K_6%;_6-N" S#'1<@YP?5R^; @R>[/.;E
M(93F.U\.K^I>]UWWU_[@IEH ZJKW*)46TB:=U)AKOB:V0J"Z^B9I3#Y>(:+J
MNXV-4=0Y/B8>L4MJ]<U68[U7>_4,1F?TRB_C%@>5?B-)0W8>QXQ4JM78T>PR
M"I7>:D.X.487WJHY.VK%M>%2W:\ ]U%+^O&_X]X"?<+_\#4A7T5*YTH_?0O7
M)<)-@PU8[=8*&#='G%J3DB2TA4YHR,X]G !F3-T')A*_EB(Q/-% '<NSN<+J
MN/ 3-T@6;I&&J+:BD3>[KO@T5:B#'7.>5&53!^B<A;%)+<Z*PJ@27O7\ABX\
MU$^I\Y,E]4]F^WRU*4^AO!L0),B+==Z W6Z%5[DU7P!=);7&T-4O&K<$Y,*H
M)J.+7C0?K><N_KX%-P0T3$A:F +7^RP4?\-H6?$L7/ZK+X39[TFK$@J5\FM:
MWI!?5US5TQ0O4*O&U!/S=RZ#..8:-AU&A-7Y/(\$KCDO-F)<%B4U,N8$Q3<1
M2+M=.?H25ECMKF&C=%73DA&2X41K:KAB'"D -4N8=AYTFEL5O6J%1'PIE%IX
M<@4*V)5IP>:T^8HH&)5.9[Z)QWH:;I?(F(?.R88]@%-3GFDUIK4K23)M]'B-
M.D&Z:#4<[^\J AI>9#SA2I?^$MF*>*C1G%Q$;"S=9XKHHAEU!@,5C%ZB>;9'
M_2&>F+$["+-SPW=4*RU-HDJM\:TR"_K*EH!OOO])HUZ^1D Z#Q?7%8,4H*I6
M8R7L ,K5!AW@!(X&G5EYR+L5CI7"*NE,1AXL6K_E&--=WD),2DG39J4JK0H\
MB.CV*7M$<-G??HBGA%C0Y5-_,4&ZZN8 "[%Q,R"5BV9KMC%D7+9;U8SQFPL/
MZP/\Q( /_AX(\8\TT_?A1+BG^1T&8#VB$,>(8M.;TJW/=;$_WI[LO>/W)T::
MVP?B@S?#?7$N7?%CPOF]">>CG4'VZ(^U_%]OT1]Y_0]02P,$%     @ !(0Y
M5O/VC&X'&@  9=(   L   !F;W)M."UK+FAT;>T]:U?BRK+?7<O_T)>S]UVZ
M#H\D/!1UN L19W!\#?B:^>)JDD:B(8E)>,VOOU7="200''7 $8=]SAJ!]*.J
MN]Y5W=G[OT''(#WFN+IE?DK(:2E!F*E:FF[>?4ITO59J._%_I?6UO;8'[:"M
MZ7Y*M#W/WLED^OU^NI]-6\Y=1BX6BYD!MDF(1CN#V':*),F9FY/CAMIF'9K2
M3=>CILI&G0S=?)@]/CX=-6TZAAYIBK\$DV0S4T/#4VW<(=RXD!$/(TV]V*9Y
MT=0+FNJNE5/DK:?@$"U&'0:SVLH(,V#(;O;KQ^/F7GS[<=.,YU#3;5E.AWJP
MASA2/B4I*:40&B3E,C4R$'Q/WUF]7XZSG<K*P3A3FQ/%%!\WJ3M:<8U-+'<P
M)SR 'HH2-'18:^:PA0P\#1IVW=0=I?:H<8NZ3=[0?Q 9U?\MY79MVV =9GHS
M^V$;WO<Q&_1V'>_)GO[SB5XPGF,9S(V=B3^)@*AY3LH;VLR-1Q\>9_ Q]I%2
MDIQ21ENA6EW3<X;QZ^L_C$P%\,8B$6ET='E^/6IUW[5UCSE]9A@F<]VT:G6P
M<5:2Y6*"2P1&-?A+\+\]3_<,5MK+B+_PM,,\2G"H%'OLZKU/B8IE>K"4J0O
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MRC"\=JN. E'CD-3/FMG9UO9/6O9I$\;[W>A >+Y$:3OU=3(T,%KA%8F\#=1
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M=LF9.'>\0XZIZZU"?Q_XM$^F:6E#Y+%,V^L8I2AE-)BW2_!E1SMDH UV2>V
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MO%JUZGO?;ZY[*<[)@,T99V*R"^XW&@TOG2V@6\C90/%"NN[9Z0'5L%#&678
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M:@:/^EQRW/PR_PI('_D_4$L#!!0    (  2$.59P@GFC,PP   >3   5
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M@QHO8[7>KX,24.\6E@[;368 <4#HM#L$".)!J!GE$Z2K-*)L0VN/.YS3+>\
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MZ"L,@W?7JC(.D"H%R6)$1J9]0=!ST/6OKODG_G7Y%?]KCC/"O_D?4$L#!!0
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M9XSO>L-$R;D/WV:',IBU5 E5=G1MM]%YVZY/!_:E!C#?BT7F[N$:AK^7_L:
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MR<3*4  3"L% _%>UP.^1B@K^3B10[+M0<$%5(^I'.I&8]YF."<\SZMOWRBY
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M1*$]FA/.WZ6:N><BAF@?!4)IUV$&<*E&%-IW<ZJF=KS[6<FEF6W6T(:H>QI
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M4$L! A0#%     @ !(0Y5C;-UL*LN   C'0$  L              ( !
M &5X,3 M,#$N:'1M4$L! A0#%     @ !(0Y5FVEHBC>I@  !EL$  L
M         ( !U;@  &5X,3 M,#(N:'1M4$L! A0#%     @ !(0Y5IVJK25X
M7   B18#  L              ( !W%\! &5X,3 M,#,N:'1M4$L! A0#%
M  @ !(0Y5NR(G0LH#   ZS4   L              ( !?;P! &5X.3DM,#$N
M:'1M4$L! A0#%     @ !(0Y5O/VC&X'&@  9=(   L              ( !
MSL@! &9O<FTX+6LN:'1M4$L! A0#%     @ !(0Y5@R)HFSU P  # \  !$
M             ( !_N(! &IU<'<M,C R,S Q,3DN>'-D4$L! A0#%     @
M!(0Y5AG@N<<B"0  AVH  !4              ( !(N<! &IU<'<M,C R,S Q
M,3E?9&5F+GAM;%!+ 0(4 Q0    (  2$.59P@GFC,PP   >3   5
M      "  7?P 0!J=7!W+3(P,C,P,3$Y7VQA8BYX;6Q02P$"% ,4    "  $
MA#E6%O4CN7 (   >90  %0              @ '=_ $ :G5P=RTR,#(S,#$Q
?.5]P<F4N>&UL4$L%!@     )  D )0(  ( % @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
